Patent Grant
11083631
This application describes embodiments of apparatuses, methods, and systems for the treatment of wounds, specifically to aid in the closure of large wounds, in conjunction with the administration of negative pressure.
Negative pressure wound therapy has been used in the treatment of wounds, and in many cases can improve the rate of healing while also removing exudates and other deleterious substances from the wound site.
Abdominal compartment syndrome is caused by fluid accumulation in the peritoneal space due to edema and other such causes, and results in greatly increased intra-abdominal pressure that may cause organ failure eventually resulting in death. Causes may include sepsis or severe trauma. Treatment of abdominal compartment syndrome may require an abdominal incision to permit decompression of the abdominal space, and as such, a large wound may be created onto the patient. Closure of this wound, while minimizing the risk of secondary infections and other complications, and after the underlying edema has subsided, then becomes a priority.
Other large or incisional wounds, either as a result of surgery, trauma, or other conditions, may also require closure. For example, wound resulting from sterniotomies, fasciotomies, and other abdominal wounds may require closure. Wound dehiscence of existing wounds is another complication that may arise, possibly due to incomplete underlying fascial closure, or secondary factors such as infection.
Existing negative pressure treatment systems, while permitting eventual wound closure, still require lengthy closure times. Although these may be combined with other tissue securement means, such as sutures, there is also a risk that underlying muscular and fascial tissue is not appropriately reapproximated so as to permit complete wound closure. Further, when foam or other wound fillers are inserted into the wound, the application of negative pressure to the wound and the foam may cause atmospheric pressure to bear down onto the wound, compressing the foam downward and outward against the margins of the wound. This downward compression of the wound filler slows the healing process and slows or prevents the joining of wound margins. Additionally, inflammation of the fascia in the form of certain types of fasciitis can lead to rapid and excessive tissue loss, potentially meriting the need for more advanced negative pressure treatment systems. Accordingly, there is a need to provide for an improved apparatus, method, and system for the treatment and closure of wounds.
Embodiments of the present invention relate to negative pressure wound closure devices, methods, and systems that facilitate closure of a wound. The devices, methods, and systems may operate to reduce the need for repetitive replacement of wound filler material currently employed and can advance the rate of healing. The devices, methods, and systems may be simultaneously used with negative pressure to remove wound fluids.
In one embodiment, a wound closure device comprises:
In some embodiments, the beams are rigid. In some embodiments, the first plurality of beams intersects with the second plurality of beams at a right angle. Some embodiments may provide for each planar support structure to be substantially rigid within the plane of the support structure. In further embodiments, the planar support structure comprises one or more standoffs located on an outer plane or perimeter. In further embodiments, the standoffs are provided with one or more tissue anchors configured to engage tissue placed into contact with the device. In some embodiments, a first plurality of spring elements is located in a first plane perpendicular to the planar support structures, and a second plurality of spring elements is located in a second plane perpendicular to both the first plane and to the planar support structures. Some embodiments may provide for the first plurality of spring elements being located in a first plurality of parallel planes, the first plurality of parallel planes including the first plurality of rigid beams, and wherein the second plurality of spring elements are located in a second plurality of parallel planes, the second plurality of parallel planes including the second plurality of rigid beams. Some embodiments may provide spring elements comprising V-shaped members. In some embodiments, each planar support structure is identical. In some embodiments, a porous material such as foam surrounds one or more of the planar support structures. In further embodiments, the porous material surrounds the entire device. In some embodiments, the stabilizing structure comprises 2, 3, 4, 5 or more parallel planar support structures, with spring elements provided between each. In some embodiments, there may be an identical arrangement of spring elements between each of the planar support structures.
Another embodiment provides for a stabilizing structure comprising a plurality of cells provided side-by-side in a plane, each cell defined by one or more walls, each cell having a top end and a bottom end with an opening extending through the top and bottom ends in the direction perpendicular to the plane; wherein the stabilizing structure is configured to collapse significantly more within the plane than along the direction perpendicular to the plane.
In some embodiments, the stabilizing structure is constructed from a material selected from the group consisting of silicone, polyurethanes, flexible plastics, rigid plastics, and foam. In some embodiments, the cells are identical; in other embodiments, one or more of the cells are differently shaped from the remaining ones. The plane may extend in a horizontal direction. In some embodiments the walls may extend in a vertical direction. In some embodiments, the walls adjoin to adjacent cells. In some embodiments, the shape of each cell is selected from the group consisting of square, diamond, oblong, oval, and parallelepiped. In some embodiments, at least one wall of each cell includes a notch or a hole. In some embodiments, at least one wall of each cell is configured to fold against another wall of the cell. Further embodiments may provide for each cell to be connected to an adjacent cell by a joint, wherein the joints are more flexible than the walls. Some joints may be more flexible than other joints in the same cell. The stabilizing structure may comprise cells that are more collapsible in a first direction along the plane than in a second direction at an angle to the first direction along the same plane. Sometimes the second direction may be perpendicular to the first direction. The stabilizing structure may comprise a plurality of first strips extending in a first direction, and a plurality of intersecting strips extending in a second direction perpendicular to the first direction, wherein the structure is collapsible in the first and second directions.
In some embodiments, the one or more walls further comprise an insert disposed therein. The insert may be more rigid than the one or more walls, and may be insertable into a preformed pocket within the one or more walls. In some embodiments, the stabilizing structure comprises one or more inserts, and wherein each of the one or more walls are molded around an individual insert. The insert may have a rectangular configuration. The insert may have a rectangular configuration with two notches formed thereupon. In some embodiments, the insert comprises one or more longitudinal grooves extending in the direction of the plane. The insert may further comprise one or more holes disposed therethrough. In some embodiments, the holes are arranged in a 6×6 pattern. In certain embodiments, the holes are arranged in a 2×3 pattern or any other pattern. The one or more holes may be disposed on an edge of the insert.
Embodiments of the wound closure device disclosed in this section or elsewhere in this specification may also comprise a porous material surrounding or within each cell of the stabilizing structures described both above and below. In some embodiments, a porous material may surround the entire stabilizing structure, or may surround only a perimeter of the stabilizing structure. The porous material may be foam. In some embodiments, porous materials may surround or be within each cell, quadrilateral space or other interior portions of the stabilizing structure. In some embodiments, the stabilizing structure may be insertable into a sock or enclosure formed of porous material such that the porous material covers at least a portion of an outer perimeter of the stabilizing structure. In some embodiments, separate porous material layers may be provided above, below, or on both upper and lower layers of the stabilizing structure. In certain embodiments, the entire wound closure device or the entire stabilizing structure is surrounded by foam. In some embodiments, the cells of the wound closure device may comprise foam or other porous material inserts. In certain embodiments, foam surrounds the perimeter of the stabilizing structure or wound closure device.
In other embodiments, a stabilizing structure sized to be inserted into a wound, comprises:
Additional embodiments provide for the at least one notch on the top strip and the at least one notch on the bottom strip to be dimensioned such that, when movably interlocked together, the top strip does not extend substantially above the bottom strip in the third direction. In further embodiments, the stabilizing structure comprises at least two top strips and at least two bottom strips so as to form at least one quadrilateral space bounded by two top strips and two bottom strips.
In other embodiments, a stabilizing structure for insertion into a wound comprises:
In some embodiments, the interlock mechanism comprises: one of the at least one top strip or bottom strip comprising two parallel clasps extending in the third direction; the other of the at least one top strip or bottom strip comprising a projection extending in the third direction; and wherein the two parallel clasps rotatably engage with the projection so as to rotate about the projection in the first plane while remaining substantially fixed in the third direction. In some embodiments, the interlock mechanism comprises: one of the top strip or the bottom strip comprising a projection with an enlarged distal end, the other of the top strip or bottom strip comprising a cup-shaped member configured to receive the enlarged distal end of the projection therein; and wherein the top strip and bottom strips are rotatably engaged so as to rotate about the projection in the first plane without disengaging in the third direction. In some embodiments, the interlock mechanism comprises: one of the at least one top strip or bottom strip comprising four clasps disposed at perpendicular angles to each other extending in the third direction; the other of the at least one top strip or bottom strip comprises a projection extending in the third direction; and wherein the two parallel clasps rotatably engage with the projection so as to rotate about the projection in the first plane while remaining substantially fixed in the third direction. Some embodiments may also comprise an uncompressed volume defined by the height of the stabilizing structure and the area of the stabilizing structure in the first plane when the first and second directions defined by the at least one top strip and bottom strip are at perpendicular angles to each other, and wherein the stabilizing structure, when compressed, defines a compressed volume that is at least 15% smaller than the uncompressed area.
Additional embodiments provide for the top strip comprising at least one notch extending partly therethrough and opening on a bottom side of the top strip, and the bottom strip comprising at least one notch extending partly therethrough and opening on a top side of the bottom strip. In such an embodiment, the interlock mechanism places the notch on the top strip over the notch on the bottom strip. In some embodiments, the at least one notch on the top strip and the at least one notch on the bottom strip to be dimensioned such that, when movably interlocked together, the top strip does not extend substantially above the bottom strip in the third direction. In further embodiments, the stabilizing structure comprises at least two top strips and at least two bottom strips so as to form at least one quadrilateral space bounded by two top strips and two bottom strips.
In some embodiments, a stabilizing structure is provided for insertion into a wound, comprising a plurality of elongate strips arranged in parallel (or generally in parallel), and a plurality of intervening members connecting the elongate strips, wherein the plurality of intervening members are configured to pivot relative to the strips to allow the plurality of elongate strips to collapse relative to one another; wherein the intervening members between a first strip and a second strip are configured to pivot independently of the intervening members between a second strip and a third strip.
In certain embodiments, the intervening members are connected to the elongate strips via at least one joint. In particular embodiments, the joint is a hinge. In some embodiments, the hinges are configured to collapse in one direction. In particular embodiments, the joints are configured to restrict the movement of the intervening members. In certain embodiments, the elongate strips are rigid. In certain embodiments, the elongate strips are configured to bend along their length. In some embodiments, the elongate strips can be constructed from a material selected from the group consisting of silicone, polyurethane, rigid plastics, semi-rigid plastics, biocompatible materials, flexible plastic materials, composite materials, and foam. In some embodiments, the intervening members are constructed from a material selected from the group consisting of silicone, polyurethane rigid plastics, semi-rigid plastics, biocompatible materials, flexible plastic materials, composite materials, and foam.
In some embodiments, the stabilizing structure comprises a plurality of intervening members between adjacent elongate strips to define a row of cells between each pair of adjacent elongate strips. In some embodiments, the cells are in the shape of a diamond. In particular embodiments, the cells in a row between adjacent elongate strips are configured to collapse together as the adjacent strips collapse relative to one another. In some embodiments, the rows of cells between adjacent strips are configured to collapse in a first direction, and one or more rows of cells between adjacent strips are configured to collapse in a second direction opposite the first direction. In some embodiments, all of the rows of cells of the stabilizing structure are configured to collapse in the same direction.
In some embodiments, the intervening members between the first strip and the second strip are offset relative to intervening members between the second strip and the third strip. In certain embodiments, foam surrounds the elongate strips and the intervening members. In some embodiments, foam is contained between adjacent elongate strips.
In certain embodiments, the intervening members comprise panels. In other embodiments, the intervening members comprise a plurality of bars configured to pivot relative to the elongate strips, and a plurality of pins connecting the elongate strips to the bars. In some embodiments, a plurality of stops is configured to restrict the rotational movement of the pins.
In further embodiments, the intervening members of the stabilizing structures described above may further comprise one or more sleeves and one or more inserts, wherein the sleeves are configured to receive one or more inserts. In certain embodiments, the inserts may be constructed from rigid or semi-rigid materials such as polyvinyl chloride. In some embodiments, the sleeves can be constructed from flexible or semi-flexible materials such as silicone or polyurethane. In other embodiments, the inserts may further comprise one or more indents.
In some embodiments, the elongate strips of the stabilizing structures described above can comprise one or more flexing segments and one or more supporting segments. The flexing segments may be constructed from flexible or semi-flexible materials such as silicone or polyurethane, while the supporting segments may be constructed from rigid or semi-rigid material such as polyvinyl chloride. In certain embodiments, the length of the supporting segments is greater than the length of the flexing segments.
In some embodiments, the elongate strips of the stabilizing structures described above can comprise holes configured to allow the passage of fluid. In additional embodiments, the elongate strips may further comprise one or more gaps that extend along at least a portion of the elongate strip. In further embodiments, the intervening members of the stabilizing structures described above can comprise one or more windows configured to allow the passage of fluid. Further embodiments may provide for windows that further comprise a bar.
In certain embodiments, the stabilizing structures as described above may be configured such that 90% of the total collapse of any dimension occurs within one hour. In other embodiments, the stabilizing structures are configured such that 90% of the total collapse of any dimension occurs within five minutes.
Further embodiments may provide for the use of separate foam layers above, below, or on both upper and lower layers of the stabilizing structure. In certain embodiments, the foam layers further comprise fingers that extend into or around the stabilizing structure. In some embodiments the stabilizing structure is surrounded by foam in the form of a ribbon or ring.
The embodiments disclosed in this section or elsewhere in this specification may also comprise a drape configured to be placed over the wound closure device or stabilizing structure once inserted into a wound so as to create a fluid-tight seal on the skin surrounding the wound. Embodiments may also comprise a source of negative pressure configured to be connected to the wound, and other associated apparatuses.
Further embodiments provide for methods of closing a wound, comprising:
Further embodiments may provide for removing fluid from the wound site. In some embodiments, the wound closure device or stabilizing structure is placed into the wound such that the direction of collapse or compression of the wound closure device or stabilizing structure is parallel or substantially parallel with the surface of the skin. In some embodiments, the application of negative pressure causes the wound closure device or stabilizing structure to at least partly collapse. Further, the wound closure device or stabilizing structure may be at least partly collapsed or compressed prior to inserting the stabilizing structure into the wound. In some embodiments, the wound closure device or stabilizing structure is capable of collapse or compression to 40% or less, 30% or less, 20% or less, 10% or less or even 5% or less of one of its original dimensions (e.g., along one of its lengths). Some embodiments provide for reducing the wound area by at least 50% upon the application of negative pressure.
Additional embodiments of a negative pressure wound closure system may comprise:
In certain embodiments, a method of closing a wound may comprise:
Further embodiments of the above method may provide a wound closure device comprising a stabilizing structure as described in this section or elsewhere in this specification, such as a stabilizing structure comprising intervening members which further comprise one or more sleeves and one or more inserts, wherein the sleeves are configured to receive one or more inserts.
Other embodiments of wound closure devices, stabilizing structures and associated apparatuses are described below.
Other features and advantages of the present invention will be apparent from the following detailed description of the invention, taken in conjunction with the accompanying drawings of which:
Embodiments disclosed in this section or elsewhere in this specification relate to apparatuses and methods of treating a wound with reduced pressure, including pump and wound dressing components and apparatuses. The apparatuses and components comprising the wound overlay and packing materials, if any, are sometimes collectively referred to in this section or elsewhere in this specification as dressings.
It will be appreciated that throughout this specification reference is made to a wound. It is to be understood that the term wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment. A wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced. Examples of such wounds include, but are not limited to, abdominal wounds or other large or incisional wounds, either as a result of surgery, trauma, sterniotomies, fasciotomies, or other conditions, dehisced wounds, acute wounds, chronic wounds, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, electrical burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.
As is used in this section or elsewhere in this specification, reduced or negative pressure levels, such as −X mmHg, represent pressure levels that are below standard atmospheric pressure, which corresponds to 760 mmHg (or 1 atm, 29.93 inHg, 101.325 kPa, 14.696 psi, etc.). Accordingly, a negative pressure value of −X mmHg reflects absolute pressure that is X mmHg below 760 mmHg or, in other words, an absolute pressure of (760−X) mmHg. In addition, negative pressure that is “less” or “smaller” than X mmHg corresponds to pressure that is closer to atmospheric pressure (e.g., −40 mmHg is less than −60 mmHg). Negative pressure that is “more” or “greater” than −X mmHg corresponds to pressure that is further from atmospheric pressure (e.g., −80 mmHg is more than −60 mmHg).
The negative pressure range for some embodiments of the present disclosure can be approximately −80 mmHg, or between about −10 mmHg and −200 mmHg. Note that these pressures are relative to normal ambient atmospheric pressure. Thus, −200 mmHg would be about 560 mmHg in practical terms. In some embodiments, the pressure range can be between about −40 mmHg and −150 mmHg. Alternatively a pressure range of up to −75 mmHg, up to −80 mmHg or over −80 mmHg can be used. Also in other embodiments a pressure range of below −75 mmHg can be used. Alternatively, a pressure range of over approximately −100 mmHg, or even −150 mmHg, can be supplied by the negative pressure apparatus. In some embodiments, the negative pressure range can be as small as about −20 mmHg or about −25 mmHg, which may be useful to reduce fistulas. In some embodiments of wound closure devices described here, increased wound contraction can lead to increased tissue expansion in the surrounding wound tissue. This effect may be increased by varying the force applied to the tissue, for example by varying the negative pressure applied to the wound over time, possibly in conjunction with increased tensile forces applied to the wound via embodiments of the wound closure devices. In some embodiments, negative pressure may be varied over time for example using a sinusoidal wave, square wave, and/or in synchronization with one or more patient physiological indices (e.g., heartbeat). Examples of such applications where additional disclosure relating to the preceding may be found include application Ser. No. 11/919,355, titled “Wound treatment apparatus and method,” filed Oct. 26, 2007, published as US 2009/0306609; and U.S. Pat. No. 7,753,894, titled “Wound cleansing apparatus with stress,” issued Jul. 13, 2010. Both applications are hereby incorporated by reference in their entirety. Other applications that may contain teachings relevant for use with the embodiments described in this section or elsewhere in this specification may include application Ser. No. 12/886,088, titled “Systems And Methods For Using Negative Pressure Wound Therapy To Manage Open Abdominal Wounds,” filed Sep. 20, 2010, published as US 2011/0213287; application Ser. No. 13/092,042, titled “Wound Dressing And Method Of Use,” filed Apr. 21, 2011, published as US 2011/0282309; and application Ser. No. 13/365,615, titled “Negative Pressure Wound Closure Device,” filed Feb. 3, 2012, published as US 2012/0209227.
It will be understood that throughout this specification in some embodiments reference is made to an elongate, elongated or longitudinal strip or strips. It is to be understood that these terms are to be broadly construed and refer in some embodiments to an elongate material having two parallel or substantially parallel faces, where in cross-section a thickness of the material as measured perpendicular to the faces is relatively smaller than a height of the material measured parallel to the faces. While in some embodiments the strips may be constructed from discrete lengths of material, in other embodiments the strips may simply refer to elongate portions of an overall structure having two parallel or substantially parallel faces. The strips in some embodiments have a rectangular or generally rectangular-shaped faces, wherein a length of the face is longer than the height of the face. In some embodiments, the length of the face may be more than 2 times, 4 times, 6 times, 8 times or 10 times greater than the height of the face.
As used in this section or elsewhere in this specification, the term “horizontal,” when referring to a wound, indicates a direction or plane generally parallel to the skin surrounding the wound. The term “vertical,” when referring to a wound, generally refers to a direction extending perpendicular to the horizontal plane. The term “longitudinal,” when referring to a wound, generally refers to a direction in the horizontal plane taken in a direction along which the wound is longest. The term “lateral,” when referring to a wound, generally refers to a direction in the horizontal plane perpendicular to the longitudinal direction. The terms “horizontal,” “vertical,” “longitudinal,” and “lateral” may also be used to describe the stabilizing structures and wound closure devices described throughout this specification. When describing these structures or devices, these terms should not be construed to require that the structures or devices necessarily be placed into a wound in a certain orientation, though in certain embodiments, it may be preferable to do so.
In some embodiments, the drape 104 may be provided with one or more corrugations or folds. Preferably, the corrugations are aligned along the longitudinal axis of the wound, and as such may support closure of the wound by preferentially collapsing in a direction perpendicular to the longitudinal axis of the wound. Such corrugations may aid in the application of contractile forces parallel to the wound surface and in the direction of wound closure. Examples of such drapes may be found in application Ser. No. 12/922,118, titled “Vacuum Closure Device,” filed Nov. 17, 2010 (published as US 2011/0054365), which is hereby incorporated by reference in its entirety.
In use, the wound 101 is prepared and cleaned. In some cases, such as abdominal wounds, a non- or minimally-adherent organ protection layer (not illustrated) may be applied over any exposed viscera. The wound packer 102 is then inserted into the wound, and is covered with the drape 104 so as to form a fluid-tight seal. A first end of the conduit 108 is then placed in fluidic communication with the wound, for example via the aperture 106. The second end of the conduit 108 is connected to the pump 110. The pump 110 may then be activated so as to supply negative pressure to the wound 101 and evacuate wound exudate from the wound 101. As will be described in additional detail below and in relation to the embodiments of the foregoing wound closure devices, negative pressure may also aid in promoting closure of the wound 101, for example by approximating opposing wound margins.
By means of a non-limiting example, an experiment was conducted to determine the effectiveness of an embodiment of the wound closure devices described above, with testing being performed on a cadaveric model. A midline incision was made through the peritoneum and into the abdominal cavity of the cadaver, which was then filled with two saline bags with a total capacity of approximately 2 L so as to provide upward tension to simulate the effects of abdominal edema and organ swelling that may be seen, for example, in abdominal compartment syndrome. These bags, together with the intestines, were placed into the wound cavity underneath an organ protection layer, as provided in the Renasys® A/B treatment kit (Smith & Nephew).
With reference to
Wound area measurements were taken before and after activation of the negative pressure source. In this example, the size of the wound area before and after application of negative pressure decreased from 167mm2 to 126mm2. This is a difference of 25%.
Stabilizing Structures and Wound Closure Devices of
The spring elements 1711, 1713 are preferably resiliently flexible and biased to be resiliently collapsible along a direction perpendicular to the plane defined by the planar support structure 1702. In some embodiments, the elements 1711, 1713 may be inelastic, and retain their shape when collapsed. In such embodiments, the spring elements or the stabilizing structure may be constructed with a ratchet mechanism that maintains the spring elements 1711, 1713 in their collapsed configuration.
In a preferred embodiment, these spring elements 1711, 1713 may be V- or U-shaped. Each spring element may comprise two elongated portions that are bent relative to each other and form an obtuse angle (as shown in
Standoffs 1707 and 1708 may be provided at the edges or along the outer faces of the structure 1701, and which may be configured to contact the wound. In some embodiments, the standoffs 1707, 1708 may be extensions of the beams 1703, 1705, or may be provided separately. In some embodiments, the standoffs 1707, 1708 may be provided with hook or anchor elements configured to anchor tissue placed into contact with them. Additionally or alternatively, hook or anchor elements attached to the structure 1701 may be provided separately from or instead of the standoffs 1707, 1708. Such hook or anchor elements may be useful to enhance fascial tissue closure by ensuring that different tissue layers (e.g., muscle tissue, fat tissue) are closed at approximately the same rate. Preferably, the hook or anchor elements are configured so as to be have a release force (once engaged into tissue) that causes no or minimal pain to the patient while permitting sufficient pulling force to be applied thereto so as to allow for wound closure. In some embodiments, different anchor elements may be used to engage different types of tissue. For example, the release force to release an anchor element from subcutaneous fatty tissue may be lower than the force needed to release another anchor element from muscle tissue.
Further, the anchor elements, by virtue of their attachment to the surrounding tissue, may be useful in helping prevent a drape or other materials placed over the wound from going into the edges between the skin and the structure 1701. In some embodiments, the anchor elements may be broken off, which may aid in sizing the device as described below so as to fit into a wound. Additionally, all or part of the structure 1701 may be covered or embedded within a porous wound filler material. In such configurations, the standoffs 1707, 1708 may be used to provide additional securement to any such wound filler material.
In use, the stabilizing structure 1701 may be cut to size as appropriate to fit the wound. Optionally, a porous material such as foam may be placed around the perimeter of the structure 1701, and may be secured using one or more of the standoffs 1707, 1708. The porous material may also surround or envelop the entire device, for example by using a foam enclosure. Foam may also be added into the entire structure 1701, including its interior portions, and if this is done during manufacturing, the structure 1701 is preferably capable of withstanding a reticulation process. Such a device comprising foam will have composite tensile structures that are to be considered when inserting the device into the wound. When inserting the device into the wound, the stabilizing structure 1701 is preferably oriented such that the planar support structures 1702 are aligned such that they are perpendicular or substantially perpendicular to the general direction of wound closure, or perpendicular or substantially perpendicular to the patient's skin. Optionally, an organ protection layer, which may comprise a polymer sheet or other flexible material, optionally provided with apertures, may be placed into contact with at least the bottom portion of the wound. A drape may be sealed over the skin surrounding the wound, and a source of negative pressure may be placed into fluid communication with the wound so as to effectuate wound closure. Further details regarding the drape, the application of negative pressure, and other apparatuses and methods that may be used with these stabilizing structures, are described below with respect to other embodiments.
By means of a non-limiting example, an experiment was conducted to determine the effectiveness of an embodiment of the wound closure devices described above, with testing being performed on a cadaveric model.
Wound area measurements before and after application of negative pressure indicated that the wound area decreased by 64%, from 152mm2 to 55mm2.
This non-limiting experiment tested a structure wrapped in foam and prestretched along its width and held in place by bendable plastic strips, but otherwise similar to the embodiments of
Stabilizing Structures and Wound Closure Devices of
In a preferred embodiment, the strips 1102, 1104 are constructed from a rigid or semi-rigid material, such as a polymer. Examples of suitable polymers include polyethylene, polypropylene, polyurethane, polyvinyl chloride, polystyrene, polyacrylate, polymethyl methacrylate, PEEK, silicone, polyurethane, polycarbonate, composites and laminates, or combinations thereof. In some embodiments, the material may include compressed or “felted” reticulated foam. Of course, other materials, such as cardboard or metal may be used. Preferably, the materials may be at least partially porous so as to permit fluid to flow through the material. Further, such properties may aid in distributing negative pressure through the device and to the wound, and may aid in removing fluid from the wound dressing. Such materials may include, for example, low density polypropylene, foamed material, or sintered material. The material used does not necessarily need to be strong along the length of the strips 1102, 1104, but should preferably be able to withstand pressure applied to a top or bottom edge. Preferably, the material is capable of withstanding the pressure from atmospheric pressure exerted on a drape when up to 200mmHg negative pressure is applied to the wound. In some embodiments, the material can withstand a force of 5 psi applied to a top or bottom edge.
In a preferred embodiment, each strip 1102, 1104 measures 180 mm long by 30mm high. The thickness of the strips 1102, 1104 may range, for example, between 1.50 to 2.40mm, although the thickness will be selected at least partly based on the ability of the material to withstand pressure being applied along its edge. The thickness is preferably balanced between keeping the material thin enough to minimize the compressed thickness of the stabilizing structure 1000, while keeping the material thick enough to avoid causing excessive localized pressure upon the wound bed. The notches 1106, 1108 may measure approximately 15mm in height, and may be spaced apart from other notches by 18 mm. Although the notches 1106, 1108 are shown with rounded bottoms, these may also be cut with squared-off or triangular bottoms. In some embodiments, the rounded edges reduce stresses onto the strips 1102, 1104 so as to prevent fracture and crack propagation, and may also increase the springiness of the stabilizing structure 1100.
It will be understood that the interlocking strips 1102, 1104 may not necessarily need to be joined together via notches. Hinges or other devices could be used to provide the articulation or movable interlocking ability illustrated above. In some embodiments, hinges may be constructed from thinner areas of the same material used to construct the strips 1102, 1104, and are configured to flex or bend to a predetermined position. The stabilizing structure 1100 could also be molded as a single piece such that the interlocking strips 1102, 1104 form a single unit.
Returning to
Advantageously for some types of wounds, the stabilizing structure of
In use, the stabilizing structure 1100 may be placed into a wound such that the upward facing portion of the structure 1100 is substantially rigid and resists collapse in the vertical direction once negative pressure is applied to the wound (e.g., once covered by a drape as described previously). A porous material such as foam may be placed around, into, and/or so as to surround or encapsulate the stabilizing structure 1100. In some embodiments, an organ protection layer as described previously may be placed into contact with at least the bottom portion of the wound. As negative pressure is applied, the structure 1100 will then preferably collapse in the plane perpendicular to the vertical direction, aiding in wound closure. Due to the relative incompressibility of the vertical dimension of the device, the pressure on the drape transmitted from the greater atmospheric pressure onto the wound will reduce the pressure applied to the stabilizing structure 1100 onto the wound margins in comparison to existing prior art devices (such as those illustrated in
As illustrated in
In some embodiments, stabilizing structures similar to those illustrated above in
Construction of a single unit stabilizing structure may be advantageous in terms of ease of use and cost. For example, single unit stabilizing structures may be trimmed as necessary to fit into a wound site. The material used is preferably biocompatible, and even more preferably nonadherent to the wound site. Suitable materials are preferably chosen to be soft while remaining sufficiently strong to resist collapse in a vertical direction, and may include polymers, such as polyethylene, polypropylene, polyurethane, silicone (including siloxanes), ethyl vinyl acetate, and copolymers and blends thereof. The hardness of the material may affect the thickness of the resulting stabilizing structure, and may be selected based upon the desired thickness of the stabilizing structure components (including hinges and other joints thereof) and the ability of the stabilizing structure to resist collapse, e.g., due to the atmospheric pressure acting upon a drape placed over the stabilizing structure. Suitable durometer hardnesses of materials used range from about 30 shore to 120 shore (as measured on the Shore durometer type A scale), preferably from about 40 shore to 60 shore, and even more preferably about 42 shore. Generally, the material chosen is preferably softer (while still satisfactorily meeting other material requirements), as harder materials may provide reduced levels of closure as the hardness increases.
In some configurations, one or both of the longitudinal strips 1120 and/or collapsible cross strips 1122 may comprise one or more notches positioned along a length thereof. These notches promote fluid transfer across the structure, and aid in distributing negative pressure. In some embodiments, notches may be used in conjunction with a porous material so as to enhance fluid transfer. In relation to the longitudinal strips 1120, the collapsible cross strips 1122 may be positioned alternately along the length of the longitudinal strips 1120, as best illustrated in
In some embodiments, the stabilizing structures described in this section or elsewhere in this specification (such as those described in
In this next non-limiting experiment, the wound described in the preceding examples had an embodiment of the stabilizing structure device described above in relation to
Wound area measurements were taken before and after activation of the negative pressure source. Here, the size of the wound before application of negative pressure was measured as 171mm2. Upon the application of negative pressure, as illustrated in
Wound area measurements before and after application of negative pressure indicated that the wound area decreased by 63%, from 155mm2 to 58mm2.
Without wishing to be bound by theory, the greater reduction in wound area in the preceding examples, as compared to the black foam control of Example 1, is believed to be due to the fact that the wound devices used therein do not significantly compress in a vertical direction when negative pressure is applied. This is different from traditional foam dressings, where the application of negative pressure causes downward pressure on the foam due to the air pressure pressing onto the drape, [thus causing the foam to collapse towards the wound bed, creating a concave shape to the drape. The atmosphere acts predominantly in a perpendicular direction to the surface of the drape. Thus, on the periphery of the concave shape, closest to the wound edge or where the drape approaches an angle perpendicular to the plane of the wound, the atmosphere now creates a force in a direction that pushes the wound apart.] Similarly, pressure is transmitted along the foam dressing into a horizontal force that pushes the wound margins outward. With the use of a stabilizing structure as used in the various examples illustrated here, the foam and other dressing components are not pushed outward, and thus the wound margins may be approximated more easily so as to achieve faster wound closure. In fact, in some experiments, certain embodiments of the wound devices projected upward over the wound margins, and these vertical surfaces may therefore allow for atmospheric pressure to produce contractile forces onto the devices and/or the wound margins.
Traditional negative pressure wound treatment typically uses foam (or other porous materials) placed into a wound underneath a drape, to which negative pressure is applied to the wound. In such situations, the application of negative pressure may cause downward pressure on the foam due to the air pressure pressing onto the drape, which is then transmitted along the foam dressing into a horizontal force that pushes the wound margins outward. Without wishing to be bound by theory, it is believed that some of the embodiments of stabilizing structures, wound closure devices, and wound treatment devices, methods, and systems described below are able to cause a greater reduction in wound area as compared to traditional negative pressure treatment. One of these factors is believed to be because embodiments of the stabilizing structures and wound closure devices described in this section or elsewhere in this specification do not significantly compress in a vertical direction when negative pressure is applied. With the use of certain embodiments described in this section or elsewhere in this specification, foam and other dressing components are not pushed outward due to negative pressure, and thus the wound margins may be approximated more easily so as to achieve faster wound closure and better wound healing.
Stabilizing Structures and Wound Closure Devices of
Each of the cells 2102 is preferably formed with four walls 2104, each wall 2104 being joined to the next by a flexible joint 2106. The joints 2106 are preferably designed so as to be more flexible than the walls 2104, and promote collapse of the stabilizing structure 2100 in the direction of the plane. Of course, it will be understood that other configurations are possible, and in some embodiments each cell 2102 may be defined by less than or greater than four walls 2104, for example five walls or six walls, thus forming pentagonal or hexagonal cells. The cells 2102 may not necessarily be symmetric, and can form rectangular, diamond, rhomboidal, trapezoidal, parallelepiped, oblong, oval, lozenge and other such shapes in addition to the square-walled embodiment illustrated in this section or elsewhere in this specification.
One or more of the walls 2104 defining the one or more cells 2102 may further comprise an insert 2115 disposed therein, and described in greater detail below in
In some embodiments, one or more notches 2109 may be provided between multiple walls 2104, and which may further aid in permitting the flexible joints 2106 to move. Without wishing to be bound by theory, the notches 2109 may also aid in distributing negative pressure and transmitting fluid throughout the stabilizing structure 2100 when negative pressure is applied, for example in a clinical care setting. Some embodiments may also comprises holes in the walls 2104 or joints 2106, or be constructed from porous materials.
Preferably, a cavity 2108 is provided within each wall 2104 for the insert 2110 to be disposed therein. The walls 2104 may be molded around each insert 2115. An insert 2115 may also be inserted into the cavity 2108 after the wall 2104 is manufactured. While the embodiment illustrated here and in the subsequent images shows a single insert 2115 in each wall 2104, some embodiments may be provided with one or more inserts 2115 disposed therein.
Similarly,
In the preceding embodiments of stabilizing structures 2100 comprising various inserts 2110, 2111, 2112, 2113, 2114, and 2115, it will of course be understood that embodiments of the stabilizing structure 2100 does not need to contain only one type of insert. Likewise, each cell 2102 or wall 2104 may comprise one or more different types of inserts, or no inserts at all. Varying the different inserts and other properties of the cells 2102 and walls 2104 may thus permit the stabilizing structure 2100 to be tailored to the appropriate wound type so as to effect optimal wound closure and/or treatment.
Turning now to
In some embodiments of any stabilizing structure described in this section or elsewhere in this specification, the width may be between about 1mm to 30mm, 2mm to 25mm, 4mm to 20mm, 6mm to 18mm, 8mm to 16mm, or 10mm to 14 mm, preferably about 10.8mm. These measurements may apply to any stabilizing structure described in this section or elsewhere in this specification.
The insert 2114 is preferably thin but with enough structural strength to resist collapse, and in some embodiments of any stabilizing structure described in this section or elsewhere in this specification, the thickness may be at least about 0.01mm to 10mm, 0.2mm to 8mm, 0.4mm to 6mm, 0.5mm to 4mm, 0.75mm to 3mm, or 1-2mm. These measurements may apply to any stabilizing structure described in this section or elsewhere in this specification.
In some embodiments of any stabilizing structure described in this section or elsewhere in this specification, multiple discrete stabilizing structures may be stacked on top of one another to form the wound closure device, to extend the height of the device to any of the dimensions described in this section or elsewhere in this specification (including the dimensions provided for the inserts above). The stacking of multiple stabilizing structures may allow the clinician to have further flexibility in their treatment strategies.
To aid in the closure of a wound, the stabilizing structure 3001 is preferably movable from the substantially un-collapsed configuration to a collapsed configuration, as illustrated in
Preferably, the structure 3001 adopts a smaller area in the first plane as a result of moving to the compressed configuration. As such, the structure 3001 aids in wound closure by aiding re-approximation of the wound margins. In some embodiments, the stabilizing structures described in this section or elsewhere in this specification are able to reduce their captured volume when in a collapsed configuration (i.e., the volume change between an uncompressed and compressed stabilizing structure) by at least 10%, preferably at least 15%, and even more preferably at least 25%.
In a preferred embodiment, the interlock mechanism 3006 preferably comprises two clasps 3010 extending downward from the top strip 3002. Preferably, the clasps 3010 are parallel to each other so as to be on opposite sides of a projection 3012 extending upward from the bottom strip 3004. The clasps 3010 preferably comprise a lip or hook 3011 that may secure themselves under an end 3013 located at the distal end of the projection 3012. In a preferred configuration, the enlarged end 3013 is arranged such that all or a portion of the lip 3011 engages with the enlarged end 3013. The combination of the lip 3011 and enlarged end 3012 may aid in preventing the top strip 3002 from disengaging in a vertical direction away from the bottom strip 3004. In some embodiments, the projection 3012 may abut on the bottom edge of the top strip 3002. In some embodiments, however, and as illustrated here, a stabilizing post 3014 may be present to locate the distal side of the projection 3012 and enlarged end 3013.
It will be noted that due to the addition of additional clasps 3010 in comparison to the embodiment illustrated in
Preferably, one or more slits 3021 are formed into the cup-shaped member 3020 so as to permit some “give” to permit the projection 3012 to be received into the cup-shaped member. A lip or hook 3022 may also aid in securing the enlarged end 3013 of the projection 3012. A stabilizing post 3014 may also be present to prevent the projection 3012 from extending too deeply into the cup-shaped member 3020.
One or more struts 3404 are preferably attached at one or more points to the long strip 3402. Preferably, these struts 3404 are movably attached, for example via a hinge-like attachment or flexible joint, such that these may collapse in a direction perpendicular to a longitudinal length defined by the length of the one or more long strips 3402. In some embodiments, the struts 3404 may be angled at a non-perpendicular angle with respect to the long strip 3402 so as to collapse more readily. In embodiments comprising two or more long strips 3402, the struts 3404 may be hinged between two parallel long strips 3402.
It will be recognized that while these struts 3404 may be configured to collapse along a direction perpendicular to the longitudinal length of the one or more long strips 3402, the struts 3404 are preferably rigid in a vertical direction (i.e., in the direction extending upward from a plane defined by the wound 3405). As such, a combination of the struts 3404 and the long strips 3402 may thus form a stabilizing structure 3400 that is substantially rigid in a vertical direction while being collapsible in a horizontal direction perpendicular to the longitudinal axis of the long strips 3402 (i.e., in the plane of the wound 3405).
Stabilizing Structures and Wound Closure Devices of
In some embodiments, the collapse can occur slowly, thereby applying increasing longitudinal tension over a long period of time. In certain embodiments, the collapse and lengthening of the structure can occur immediately upon application of negative pressure. In further embodiments, the collapse can occur at any rate.
In some embodiments, the elongate strips 3502 are rigid. In certain embodiments, the elongate strips 3502 are semi-rigid. In particular embodiments, the elongate strips 3502 are flexible. In some embodiments, the elongate strips 3502 are compressible. As illustrated in
In some embodiments, the intervening members 3504 are rigid. In certain embodiments the intervening members 3504 are semi-rigid. In particular embodiments, the intervening members are flexible. In some embodiments, the intervening members 3504 are compressible. As illustrated in
In some embodiments, the plurality of intervening members 3504 are configured to pivot relative to the elongate strips 3502 and to collapse so as to allow the elongate strips to collapse relative to one another and come closer together. In some embodiments, the joints 3506 are configured to pivot and collapse in only one direction. In certain embodiments, the joints 3506 are configured to pivot and collapse in both directions, comprising a full 180 degrees of rotation relative to the elongate strips 3502. In certain embodiments, when the joints pivot, they pivot completely so as to rest the intervening members 3504 against the elongate strips 3502. In some embodiments, the joints do not pivot completely and the intervening members do not come to rest against the elongate strips 3502.
Preferentially, in certain embodiments, by controlling the direction in which the pivoting occurs, the collapsed length of the stabilizing structure 3500 can be controlled. In particular embodiments, because of the rigidity of the elongate strips, the cells 3508 in a row between adjacent elongate strips are configured to collapse together as the adjacent elongate strips 3502 collapse relative to one another. In some embodiments, one or more rows of cells 3508 between adjacent strips 3502 are configured to collapse in a first direction, and one or more rows of cells between adjacent strips 3502 are configured to collapse in a second direction opposite the first direction. As illustrated in
By configuring the joints 3506 and/or cells of the stabilizing structure to pivot and collapse in preferred directions, the length of the collapsed structure can be modified. The embodiment shown in
In
As shown in
In certain preferred embodiments, the joint 3506 may be configured to limit the range of motion of the intervening member 3504, and may be used to prevent the intervening members 3504 from becoming fully perpendicular to the adjacent strips. Thus, the joint may be configured to pre-set the intervening members 3504 in a partially collapsed position. For example, a lip or other portion of material at the joint may be used to limit the angular motion of the intervening members. The lip or other portion of material may also prevent the joint from collapsing completely flat. In some embodiments, the joint may be configured to prevent the intervening members from rotating in 180 degrees along the plane formed by the strips.
In some embodiments, when the stabilizing structure 3500 is placed in a wound, the elongate strips 3502 are positioned generally parallel to the lateral edges of the wound. Preferably, the stabilizing structure is configured in the wound such that the elongate strips are positioned parallel to the longitudinal axis of the wound, as described with respect to
In the embodiments of
Preferably, as illustrated in the top view of
As illustrated in
In the
Stabilizing Structures and Wound Closure Devices of
The stabilizing structure 4200 and all stabilizing structures and wound closure devices described in this section or elsewhere in this specification can collapse on a variety of timescales in a dynamic fashion. In certain embodiments, the majority of the collapse may occur within the first few minutes upon application of negative pressure. However, after the initial collapse, the stabilizing structure or wound closure device may continue to collapse at a much slower rate, thereby applying increasing longitudinal tension over a long period of time and drawing the edges of the wound closer together. By slowly drawing the wound edges closer together over time, the stabilizing structure or wound closure device allows the surrounding healing tissue to remodel synergistically with the closure of the device or stabilizing structure. Slow, dynamic wound closure may allow the surrounding tissue to heal at an accelerated rate, because the collapsing structure or device slowly brings the edges of the wound closer together without stressing the newly formed or weakened tissue too quickly.
In some embodiments, the stabilizing structures described in this section or elsewhere in this specification can placed into a wound for a period of time and then removed or replaced with another stabilizing structure. For example, a stabilizing structure could be inserted into a wound for a period of time, promoting closure of the wound by drawing the edges closer together. After a period of time has passed, the stabilizing structure can be replaced by a stabilizing structure of a different size or collapsibility, for example a stabilizing structure of a smaller size or decreased density. This process could be repeated over and over, thereby continuously drawing the edges of the wound together over time and allowing for continuing repair and remodeling of the surrounding tissue.
In some embodiments, the stabilizing structure is configured to remain in the wound for at least about less than 1 hour, at least about 1 hour, at least about 2 hours, at least about 4 hours, at least about 6 hours, at least about 8 hours, at least about 12 hours, at least about 24 hours, at least about 2 days, at least about 4 days, at least about 6 days, at least about 1 week, at least about 2 weeks, at least about 3 weeks, or more than 3 weeks.
In certain embodiments, up to 90% of the collapse of the stabilizing structure or wound closure device may occur within the first few minutes upon application of negative pressure, while the remaining 10% of the collapse may occur slowly over a period of many minutes, hours, days, weeks, or months. In other embodiments, up to about 80% of the collapse, up to about 70%, up to about 60%, up to about 50%, up to about 40%, up to about 30%, up to about 20%, up to about 10%, or about 0% of the collapse will occur immediately within the first few minutes upon application of negative pressure while the remainder of the collapse occurs at a much slower rate such as over the course of many minutes, hours, days weeks, or months. In other embodiments, the stabilizing structure can collapse at a variable rate.
In some embodiments, the entirety of the collapse occurs at a slowed rate, while in other embodiments the entirety of the collapse occurs almost immediately within the first few minutes. In further embodiments, the collapse can occur at any rate and the rate can vary over time. In certain embodiments, the rate of collapse can be altered in a variable fashion by adding and/or removing portions of the structure or by controlling the application of negative pressure and irrigant fluid.
As illustrated in the perspective view of
The joints 4206 are configured to allow the intervening members 4204 to collapse, similar to the joints described in
The elongate strips 4202 may comprise alternating flexing segments 4212 and supporting segments 4214. In a preferred embodiment, the flexing segments 4212 can be constructed from a flexible or semi-flexible material such as silicone and/or polyurethane. However, any flexible or semi-flexible material may be suitable. The flexing segments 4212 can flex in any direction, allowing the stabilizing structure to collapse more readily in any direction, but particularly in the horizontal plane. In a preferred embodiment, the supporting segments 4214 can be constructed from a rigid or semi-rigid material such as polyvinyl chloride (PVC). However, any rigid or semi-rigid material may be suitable. In the embodiment illustrated, the elongate strips 4202 comprise elongate strips of a first material such as silicone and/or polyurethane, with a plurality of elongate inserts of a second, more rigid material 4214 embedded into the first material. Thus, the flexing segments 4212 are the areas in the elongate strips 4202 where the more rigid inserts are not located.
As illustrated in
In some embodiments, the supporting segment does not alternate with the flexing segment 4212 and instead, the elongate strips 4202 are comprised entirely of supporting segments 4214 (e.g., a silicone strip or other material with an embedded more rigid insert extending the entire length thereof, or simply a more rigid material by itself). Alternatively, the entirety of the elongate strip 4202 can be comprised only of flexing segments 4212 (e.g., a strip made only of silicone or other more flexible material).
The elongate strips 4202 may be manufactured from a female mold that may further encompass the entire stabilizing structure 4200. The supporting segments 4214 can be inserted into the female mold, followed by an injection of a flexible polymer such as silicone and/or polyurethane to encase the supporting segments 4214 within the flexible polymer frame. The supporting segments 4214 can be inserted into the mold in any desired manner or quantity, allowing for many potential variations of the stabilizing device.
In further embodiments, the supporting segments 4214 are insertable and/or removable from the elongate strips 4202, and may be inserted and/or removed to alter the collapsibility of the stabilizing structure 4200. Supporting segments 4214 can be inserted and/or removed from the stabilizing structure 4200 after it has been placed in a wound to variably control the collapse of the stabilizing structure 4200. In such embodiments, the elongate strips 4202 may form pockets that are open from one side (e.g., from the top) to allow insertion and removal of the supporting segments 4214.
The intervening members 4204 in some embodiments may comprise a first material 4216 with an embedded insert 4218 made of a more rigid material. One embodiment of the embedded insert is illustrated in
In some embodiments, the stabilizing structure 4200 of
In some embodiments, the inserts 4218 may be entombed within first material 4216 in a variable number of intervening members 4204 to control the shape and collapse of the stabilizing structure 4200. In other embodiments, the inserts 4218 may be inserted directly into sleeves comprised of first material 4216 within the intervening members 4204 to control the shape and collapse of the stabilizing structure 4200.
For example, the inserts 4218 can be present in at least about 5% of the intervening members, at least about 10% of the intervening members, at least about 15% of the intervening members, at least about 20% of the intervening members, at least about 25% of the intervening members , at least about 30% of the intervening members, at least about 35% of the intervening members, at least about 40% of the intervening members, at least about 45% of the intervening members, at least about 50% of the intervening members, at least about 55% of the intervening members, at least about 60% of the intervening members, at least about 65% of the intervening members, at least about 70% of the intervening members, at least about 75% of the intervening members, at least about 80% of the intervening members, at least about 85% of the intervening members, at least about 90% of the intervening members, at least about 95% of the intervening members, or about 100% of the intervening members.
In certain embodiments, a variable number of supporting segments 4214 may be entombed within elongate strips 4202 to control the collapsibility of the stabilizing structure 4200. In other embodiments, a variable number of supporting segments may be inserted into a pocket contained within the elongate strips 4202 to control the collapsibility of the stabilizing structure. For example, the supporting segments 4214 can be present in at least about 5% of the total length of the elongate strips, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50% , at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or about 100% of the total length of the elongate strips.
In certain embodiments, the inserts 4218 or supporting segments 4214 may be inserted and/or removed over time to variably control the collapse of the stabilizing structure 4200. For example, although initially all the available sleeves 4216 of the stabilizing structure may contain an insert, after the initial placement of the stabilizing structure in a wound, additional inserts 4218 may be removed over time, thus causing the stabilizing structure 4200 to collapse even further. Inserts can also be added to the stabilizing structure after it is inserted into a wound, thereby decreasing the collapsibility of the stabilizing structure 4200. Thus, the addition and/or removal of the inserts 4216 or supporting segments 4214 allows for variable control of the collapse of the stabilizing structure 4200. In similar fashion, supporting segments 4214 can be inserted and removed from the elongated strips over time to provide variable control over the collapse of the stabilizing structure 4200.
In certain embodiments of the stabilizing structures described in this section or elsewhere in this specification, such as in stabilizing structure 4200 as described in
As described above in relation to
In certain embodiments, at least about 5% of the intervening members comprise windows, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50%, at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or about 100% of the intervening members.
The elongate strip 4502 may further comprise a gap 4508, configured to allow the passage of fluid. The gap may extend nearly the entire length of the elongate strips 4502 or extend only a portion of the length of the elongate strip 4502.
The foam layer 4600 further comprises fingers 4602, that can extend from the foam layer into the stabilizing structure or closure device. For example, the fingers 4602 may extend into and around the gaps or cells depicted in the stabilizing structures of
In some embodiments, the foam layer 4600 can have perforations or pre-cuts to allow portions of the foam layer 4600 to be easily torn away to shape the foam for a particular wound. In some embodiments, the fingers 4602 can extend at least about 1mm from the surface of the foam layer, at least about 3mm from the surface of the foam layer, at least about 5mm from the surface of the foam layer, at least about 7.5mm from the surface of the foam layer, at least about 10mm from the surface of the foam layer, at least about 12.5mm from the surface of the foam layer, at least about 25mm from the surface of the foam layer, at least about 17.5mm from the surface of the foam layer, at least about 20mm from the surface of the foam layer, at least about 25mm from the surface of the foam layer, or more than 25mm.
In other embodiments, the stabilizing structure is rounded at the edges to fit more closely within the shape of the wound. The stabilizing structure may be cut or bent to a desired shape. For example, the stabilizing structure may be made into the shape of an oval to better fit into wounds shaped like an oval. Further, as described in this section or elsewhere in this specification, in some embodiments the stabilizing structure may have perforations or preformed cuts, allowing portions of the stabilizing structure to be torn away to create a desired shape.
In some embodiments, the foams may be configured to degrade or dissolve over time, thereby allowing foam inserts to prop the stabilizing structure open initially, before later degrading or dissolving in a controlled manner to control the rate of collapse of the stabilizing structure. In further embodiments, the foam inserts may be impregnated with biologically active materials that may promote wound healing. For example, the biologically active materials may be anti-inflammatory molecules, growth factors, or anti-microbials.
The stabilizing structures and/or wound closure devices described in this section or elsewhere in this specification may be used in conjunction with methods or systems for the closure of a wound. In some embodiments of methods of use for closure of a wound, one or more of the stabilizing structures or wound closure devices of any of the embodiments described in this section or elsewhere in this specification is placed into a wound. In some embodiments, an organ protection layer may be provided in the wound before placement of the stabilizing structure. In certain embodiments, foam or other porous material may be placed in the wound along with the stabilizing structure or wound closure device, either below, above, or surrounding the stabilizing structure or wound closure device. Foam or other porous material may also surround the perimeter of the stabilizing structure or wound closure device. The stabilizing structure or wound closure device may be configured to collapse in any manner as described in this section or elsewhere in this specification, for example by having a particular size and shape, or by comprising a certain volume of foam or other porous material within the cells of the structure. The stabilizing structure or wound closure device may further be altered in any manner described in this section or elsewhere in this specification so as to better accommodate the shape of the wound. After placement in the wound, the stabilizing structure or wound closure device can be sealed by a fluid-tight drape. The fluid-tight drape can comprise a port configured for the application of negative pressure. A source of negative pressure may then be connected to the port and negative pressure may be applied to the wound. The stabilizing structure or wound closure device may be replaced over time by stabilizing structures or wound closure devices of various shapes and sizes as desired to best promote wound healing.
Features, materials, characteristics, or groups described in conjunction with a particular aspect, embodiment, or example are to be understood to be applicable to any other aspect, embodiment or example described in this section or elsewhere in this specification unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The protection is not restricted to the details of any foregoing embodiments. The protection extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of protection. Indeed, the novel methods and systems described in this section or elsewhere in this specification may be embodied in a variety of other forms. Furthermore, various omissions, substitutions and changes in the form of the methods and systems described in this section or elsewhere in this specification may be made. Those skilled in the art will appreciate that in some embodiments, the actual steps taken in the processes illustrated and/or disclosed may differ from those shown in the figures. Depending on the embodiment, certain of the steps described above may be removed, others may be added. Furthermore, the features and attributes of the specific embodiments disclosed above may be combined in different ways to form additional embodiments, all of which fall within the scope of the present disclosure.
Although the present disclosure includes certain embodiments, examples and applications, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof, including embodiments which do not provide all of the features and advantages set forth in this section or elsewhere in this specification. Accordingly, the scope of the present disclosure is not intended to be limited by the specific disclosures of preferred embodiments in this section or elsewhere in this specification, and may be defined by claims as presented in this section or elsewhere in this specification or as presented in the future.
This application is a divisional of U.S. application Ser. No. 14/415,470, filed Jan. 16, 2015, which is a National Stage Application of International Patent Application No. PCT/US2013/050698, filed Jul. 16, 2013, which claims the benefit of U.S. Provisional Application No. 61/672,225, filed Jul. 16, 2012, entitled NEGATIVE PRESSURE WOUND CLOSURE DEVICE, U.S. Provisional Application No. 61/771,732, filed Mar. 1, 2013, entitled NEGATIVE PRESSURE WOUND CLOSURE DEVICE, and U.S. Provisional Application No. 61/780,629, filed Mar. 13, 2013, entitled NEGATIVE PRESSURE WOUND CLOSURE DEVICE. The contents of the aforementioned applications are hereby incorporated by reference in their entireties as if fully set forth in this specification. The benefit of priority to the foregoing applications is claimed under the appropriate legal basis, including, without limitation, under 35 U.S.C. § 119(e).
| Number | Name | Date | Kind |
|---|---|---|---|
| 1006716 | Bloomer | Oct 1911 | A |
| 3014483 | Frank et al. | Dec 1961 | A |
| 3194239 | Sullivan | Jul 1965 | A |
| 3578003 | Everett | May 1971 | A |
| 3789851 | Leveen | Feb 1974 | A |
| 3812616 | Koziol | May 1974 | A |
| 3952633 | Nakai | Apr 1976 | A |
| 4000845 | Zeller | Jan 1977 | A |
| 4467805 | Fukuda | Aug 1984 | A |
| 4608041 | Nielsen | Aug 1986 | A |
| 4637819 | Ouellette et al. | Jan 1987 | A |
| 4699134 | Samuelsen | Oct 1987 | A |
| 4771482 | Shlenker | Sep 1988 | A |
| 4815468 | Annand | Mar 1989 | A |
| 5176663 | Svedman et al. | Jan 1993 | A |
| 5264218 | Rogozinski | Nov 1993 | A |
| 5332149 | Gepfer | Jul 1994 | A |
| 5368910 | Langdon | Nov 1994 | A |
| 5368930 | Samples | Nov 1994 | A |
| 5376067 | Daneshvar | Dec 1994 | A |
| 5409472 | Rawlings et al. | Apr 1995 | A |
| 5415715 | Delage et al. | May 1995 | A |
| 5423857 | Rosenman et al. | Jun 1995 | A |
| 5512041 | Bogart | Apr 1996 | A |
| 5514105 | Goodman, Jr. et al. | May 1996 | A |
| 5562107 | Lavender et al. | Oct 1996 | A |
| 5584859 | Brotz | Dec 1996 | A |
| 5636643 | Argenta et al. | Jun 1997 | A |
| 5695777 | Donovan et al. | Dec 1997 | A |
| 5853863 | Kim | Dec 1998 | A |
| 5928210 | Ouellette et al. | Jul 1999 | A |
| 5960497 | Castellino et al. | Oct 1999 | A |
| 6080168 | Levin et al. | Jun 2000 | A |
| 6086591 | Bojarski | Jul 2000 | A |
| 6142982 | Hunt et al. | Nov 2000 | A |
| 6176868 | Detour | Jan 2001 | B1 |
| 6291050 | Cree et al. | Sep 2001 | B1 |
| 6471715 | Weiss | Oct 2002 | B1 |
| 6500112 | Khouri | Dec 2002 | B1 |
| 6503208 | Skovlund | Jan 2003 | B1 |
| 6530941 | Muller et al. | Mar 2003 | B1 |
| 6548727 | Swenson | Apr 2003 | B1 |
| 6553998 | Heaton et al. | Apr 2003 | B2 |
| 6566575 | Stickels et al. | May 2003 | B1 |
| 6641575 | Lonky | Nov 2003 | B1 |
| 6685681 | Lockwood et al. | Feb 2004 | B2 |
| 6695823 | Lina et al. | Feb 2004 | B1 |
| 6712830 | Esplin | Mar 2004 | B2 |
| 6712839 | Lonne | Mar 2004 | B1 |
| 6767334 | Randolph | Jul 2004 | B1 |
| 6770794 | Fleischmann | Aug 2004 | B2 |
| 6776769 | Smith | Aug 2004 | B2 |
| 6787682 | Gilman | Sep 2004 | B2 |
| 6814079 | Heaton et al. | Nov 2004 | B2 |
| 6883531 | Perttu | Apr 2005 | B1 |
| 6893452 | Jacobs | May 2005 | B2 |
| 6936037 | Bubb et al. | Aug 2005 | B2 |
| 6951553 | Bubb et al. | Oct 2005 | B2 |
| 6977323 | Swenson | Dec 2005 | B1 |
| 6994702 | Johnson | Feb 2006 | B1 |
| 7004915 | Boynton et al. | Feb 2006 | B2 |
| 7025755 | Epstein et al. | Apr 2006 | B2 |
| 7070584 | Johnson et al. | Jul 2006 | B2 |
| 7117869 | Heaton et al. | Oct 2006 | B2 |
| 7128735 | Weston et al. | Oct 2006 | B2 |
| 7144390 | Hannigan et al. | Dec 2006 | B1 |
| 7153312 | Torrie et al. | Dec 2006 | B1 |
| 7156862 | Jacobs et al. | Jan 2007 | B2 |
| 7172615 | Morriss et al. | Feb 2007 | B2 |
| 7189238 | Lombardo et al. | Mar 2007 | B2 |
| 7196054 | Drohan et al. | Mar 2007 | B1 |
| 7198046 | Argenta et al. | Apr 2007 | B1 |
| 7216651 | Argenta et al. | May 2007 | B2 |
| D544092 | Lewis | Jun 2007 | S |
| 7262174 | Jiang et al. | Aug 2007 | B2 |
| 7279612 | Heaton et al. | Oct 2007 | B1 |
| 7315183 | Hinterscher | Jan 2008 | B2 |
| 7351250 | Zamierowski | Apr 2008 | B2 |
| 7361184 | Joshi | Apr 2008 | B2 |
| 7367342 | Butler | May 2008 | B2 |
| 7381211 | Zamierowski | Jun 2008 | B2 |
| 7381859 | Hunt et al. | Jun 2008 | B2 |
| 7413571 | Zamierowski | Aug 2008 | B2 |
| 7438705 | Karpowicz et al. | Oct 2008 | B2 |
| 7494482 | Orgill et al. | Feb 2009 | B2 |
| 7524315 | Blott et al. | Apr 2009 | B2 |
| 7534240 | Johnson | May 2009 | B1 |
| 7540848 | Hannigan et al. | Jun 2009 | B2 |
| 7553306 | Hunt et al. | Jun 2009 | B1 |
| 7553923 | Williams et al. | Jun 2009 | B2 |
| 7569742 | Haggstrom et al. | Aug 2009 | B2 |
| 7578532 | Schiebler | Aug 2009 | B2 |
| D602583 | Pidgeon et al. | Oct 2009 | S |
| 7611500 | Lina et al. | Nov 2009 | B1 |
| 7612248 | Burton et al. | Nov 2009 | B2 |
| 7615036 | Joshi et al. | Nov 2009 | B2 |
| 7617762 | Ragner | Nov 2009 | B1 |
| 7618382 | Vogel et al. | Nov 2009 | B2 |
| 7622629 | Aali | Nov 2009 | B2 |
| 7625362 | Boehringer et al. | Dec 2009 | B2 |
| 7645269 | Zamierowski | Jan 2010 | B2 |
| 7651484 | Heaton et al. | Jan 2010 | B2 |
| 7670323 | Hunt et al. | Mar 2010 | B2 |
| 7678102 | Heaton | Mar 2010 | B1 |
| 7683667 | Kim et al. | Mar 2010 | B2 |
| 7699823 | Haggstrom et al. | Apr 2010 | B2 |
| 7699830 | Martin et al. | Apr 2010 | B2 |
| 7699831 | Bengtson et al. | Apr 2010 | B2 |
| 7700819 | Ambrosio et al. | Apr 2010 | B2 |
| 7708724 | Weston et al. | May 2010 | B2 |
| 7713743 | Villanueva et al. | May 2010 | B2 |
| 7722528 | Arnal et al. | May 2010 | B2 |
| 7723560 | Lockwood et al. | May 2010 | B2 |
| 7753894 | Blott et al. | Jul 2010 | B2 |
| 7754937 | Boehringer et al. | Jul 2010 | B2 |
| 7776028 | Miller et al. | Aug 2010 | B2 |
| 7777522 | Yang et al. | Aug 2010 | B2 |
| 7779625 | Joshi et al. | Aug 2010 | B2 |
| D625801 | Pidgeon et al. | Oct 2010 | S |
| 7811269 | Boynton et al. | Oct 2010 | B2 |
| 7815616 | Boehringer et al. | Oct 2010 | B2 |
| 7820453 | Heylen et al. | Oct 2010 | B2 |
| 7846141 | Weston | Dec 2010 | B2 |
| 7857806 | Karpowicz et al. | Dec 2010 | B2 |
| 7863495 | Aali | Jan 2011 | B2 |
| 7892181 | Christensen et al. | Feb 2011 | B2 |
| 7896856 | Petrosenko et al. | Mar 2011 | B2 |
| 7909805 | Weston et al. | Mar 2011 | B2 |
| 7910789 | Sinyagin | Mar 2011 | B2 |
| 7931774 | Hall et al. | Apr 2011 | B2 |
| 7942866 | Radl et al. | May 2011 | B2 |
| 7951124 | Boehringer et al. | May 2011 | B2 |
| 7964766 | Blott et al. | Jun 2011 | B2 |
| 7976519 | Bubb et al. | Jul 2011 | B2 |
| 7976524 | Kudo et al. | Jul 2011 | B2 |
| 7981098 | Boehringer et al. | Jul 2011 | B2 |
| 8030534 | Radl et al. | Oct 2011 | B2 |
| 8057447 | Olson et al. | Nov 2011 | B2 |
| 8062272 | Weston et al. | Nov 2011 | B2 |
| 8062295 | McDevitt et al. | Nov 2011 | B2 |
| 8062331 | Zamierowski | Nov 2011 | B2 |
| 8067662 | Aali et al. | Nov 2011 | B2 |
| 8070773 | Zamierowski | Dec 2011 | B2 |
| 8080702 | Blott et al. | Dec 2011 | B2 |
| 8100887 | Weston et al. | Jan 2012 | B2 |
| 8114126 | Heaton et al. | Feb 2012 | B2 |
| 8123781 | Zamierowski | Feb 2012 | B2 |
| 8128615 | Blott et al. | Mar 2012 | B2 |
| 8129580 | Wilkes et al. | Mar 2012 | B2 |
| 8142419 | Heaton et al. | Mar 2012 | B2 |
| 8162909 | Blott et al. | Apr 2012 | B2 |
| 8172816 | Kazala, Jr. et al. | May 2012 | B2 |
| 8182413 | Browning | May 2012 | B2 |
| 8187237 | Seegert | May 2012 | B2 |
| 8188331 | Barta et al. | May 2012 | B2 |
| 8192409 | Hardman et al. | Jun 2012 | B2 |
| 8197467 | Heaton et al. | Jun 2012 | B2 |
| 8207392 | Haggstrom et al. | Jun 2012 | B2 |
| 8215929 | Shen et al. | Jul 2012 | B2 |
| 8235955 | Blott et al. | Aug 2012 | B2 |
| 8235972 | Adahan | Aug 2012 | B2 |
| 8246590 | Hu et al. | Aug 2012 | B2 |
| 8246606 | Stevenson et al. | Aug 2012 | B2 |
| 8246607 | Karpowicz et al. | Aug 2012 | B2 |
| 8257328 | Augustine et al. | Sep 2012 | B2 |
| 8273105 | Cohen et al. | Sep 2012 | B2 |
| 8298200 | Vess et al. | Oct 2012 | B2 |
| 8328776 | Kelch et al. | Dec 2012 | B2 |
| 8337411 | Nishtala et al. | Dec 2012 | B2 |
| 8353931 | Stopek et al. | Jan 2013 | B2 |
| 8357131 | Olson | Jan 2013 | B2 |
| 8362315 | Aali | Jan 2013 | B2 |
| 8376972 | Fleischmann | Feb 2013 | B2 |
| 8399730 | Kazala, Jr. et al. | Mar 2013 | B2 |
| 8430867 | Robinson et al. | Apr 2013 | B2 |
| 8439882 | Kelch | May 2013 | B2 |
| 8444392 | Turner et al. | May 2013 | B2 |
| 8444611 | Wilkes et al. | May 2013 | B2 |
| 8447375 | Shuler | May 2013 | B2 |
| 8454990 | Canada et al. | Jun 2013 | B2 |
| 8460255 | Joshi et al. | Jun 2013 | B2 |
| 8460257 | Locke et al. | Jun 2013 | B2 |
| 8481804 | Timothy | Jul 2013 | B2 |
| 8486032 | Seegert et al. | Jul 2013 | B2 |
| 8500704 | Boehringer et al. | Aug 2013 | B2 |
| 8500776 | Ebner | Aug 2013 | B2 |
| 8523832 | Seegert | Sep 2013 | B2 |
| 8535296 | Blott et al. | Sep 2013 | B2 |
| 8562576 | Hu et al. | Oct 2013 | B2 |
| 8608776 | Coward et al. | Dec 2013 | B2 |
| 8622981 | Hartwell et al. | Jan 2014 | B2 |
| 8628505 | Weston | Jan 2014 | B2 |
| 8632523 | Eriksson et al. | Jan 2014 | B2 |
| 8673992 | Eckstein et al. | Mar 2014 | B2 |
| 8679080 | Kazala, Jr. et al. | Mar 2014 | B2 |
| 8679153 | Dennis | Mar 2014 | B2 |
| 8680360 | Greener et al. | Mar 2014 | B2 |
| 8708984 | Robinson et al. | Apr 2014 | B2 |
| 8715256 | Greener | May 2014 | B2 |
| 8721629 | Hardman et al. | May 2014 | B2 |
| 8746662 | Poppe | Jun 2014 | B2 |
| 8747375 | Barta et al. | Jun 2014 | B2 |
| 8764732 | Hartwell | Jul 2014 | B2 |
| 8784392 | Vess et al. | Jul 2014 | B2 |
| 8791315 | Lattimore et al. | Jul 2014 | B2 |
| 8791316 | Greener | Jul 2014 | B2 |
| 8801685 | Armstrong et al. | Aug 2014 | B2 |
| 8802916 | Edward et al. | Aug 2014 | B2 |
| 8814842 | Coulthard et al. | Aug 2014 | B2 |
| 8821535 | Greener | Sep 2014 | B2 |
| 8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
| 8853486 | Wild et al. | Oct 2014 | B2 |
| 8882730 | Zimnitsky et al. | Nov 2014 | B2 |
| 8936618 | Sealy et al. | Jan 2015 | B2 |
| 8945030 | Weston et al. | Feb 2015 | B2 |
| 8951235 | Allen et al. | Feb 2015 | B2 |
| 8956336 | Haggstrom et al. | Feb 2015 | B2 |
| 9044579 | Blott et al. | Jun 2015 | B2 |
| 9050398 | Armstrong et al. | Jun 2015 | B2 |
| 9061095 | Adie et al. | Jun 2015 | B2 |
| 9084845 | Adie et al. | Jul 2015 | B2 |
| 9180231 | Greener | Nov 2015 | B2 |
| 9204801 | Locke et al. | Dec 2015 | B2 |
| 9220822 | Hartwell | Dec 2015 | B2 |
| 9226737 | Dunn | Jan 2016 | B2 |
| 9301742 | Dunn | Apr 2016 | B2 |
| 9339248 | Tout et al. | May 2016 | B2 |
| 9352076 | Boynton et al. | May 2016 | B2 |
| 9408755 | Larsson et al. | Aug 2016 | B2 |
| 9421132 | Dunn et al. | Aug 2016 | B2 |
| 9555170 | Fleischmann | Jan 2017 | B2 |
| 9597484 | Dunn | Mar 2017 | B2 |
| 9655807 | Locke et al. | May 2017 | B2 |
| 9737649 | Begin et al. | Aug 2017 | B2 |
| 9757500 | Locke et al. | Sep 2017 | B2 |
| 9770368 | Robinson et al. | Sep 2017 | B2 |
| 9801986 | Greener | Oct 2017 | B2 |
| 9820888 | Greener et al. | Nov 2017 | B2 |
| D805039 | Dejanovic et al. | Dec 2017 | S |
| 9844472 | Hammond et al. | Dec 2017 | B2 |
| 9849023 | Hall et al. | Dec 2017 | B2 |
| 9895270 | Coward et al. | Feb 2018 | B2 |
| 9962295 | Dunn et al. | May 2018 | B2 |
| 10070994 | Dodd et al. | Sep 2018 | B2 |
| 10117782 | Dagger et al. | Nov 2018 | B2 |
| 10124098 | Dunn et al. | Nov 2018 | B2 |
| 10130520 | Dunn et al. | Nov 2018 | B2 |
| 10143485 | Locke et al. | Dec 2018 | B2 |
| 10179073 | Hartwell et al. | Jan 2019 | B2 |
| 10201642 | Hartwell et al. | Feb 2019 | B2 |
| 10245185 | Hicks et al. | Apr 2019 | B2 |
| 10405861 | Dunn | Sep 2019 | B2 |
| 10537657 | Phillips et al. | Jan 2020 | B2 |
| 10575991 | Dunn | Mar 2020 | B2 |
| 10660992 | Canner et al. | May 2020 | B2 |
| 10814049 | Dunn | Oct 2020 | B2 |
| 20010029956 | Argenta et al. | Oct 2001 | A1 |
| 20010034499 | Sessions et al. | Oct 2001 | A1 |
| 20020022861 | Jacobs et al. | Feb 2002 | A1 |
| 20020077661 | Saadat | Jun 2002 | A1 |
| 20020161346 | Lockwood et al. | Oct 2002 | A1 |
| 20030065360 | Jacobs et al. | Apr 2003 | A1 |
| 20030108587 | Orgill et al. | Jun 2003 | A1 |
| 20030114816 | Underhill et al. | Jun 2003 | A1 |
| 20030114818 | Benecke et al. | Jun 2003 | A1 |
| 20030114821 | Underhill et al. | Jun 2003 | A1 |
| 20030120249 | Wulz et al. | Jun 2003 | A1 |
| 20030121588 | Pargass et al. | Jul 2003 | A1 |
| 20030178274 | Chi | Sep 2003 | A1 |
| 20030220660 | Kortenbach et al. | Nov 2003 | A1 |
| 20040006319 | Lina et al. | Jan 2004 | A1 |
| 20040010275 | Jacobs et al. | Jan 2004 | A1 |
| 20040054346 | Zhu et al. | Mar 2004 | A1 |
| 20040064132 | Boehringer et al. | Apr 2004 | A1 |
| 20040147465 | Jiang et al. | Jul 2004 | A1 |
| 20040162512 | Liedtke et al. | Aug 2004 | A1 |
| 20040243073 | Lockwood et al. | Dec 2004 | A1 |
| 20040267312 | Kanner et al. | Dec 2004 | A1 |
| 20050107731 | Sessions | May 2005 | A1 |
| 20050119694 | Jacobs, I et al. | Jun 2005 | A1 |
| 20050131414 | Chana | Jun 2005 | A1 |
| 20050142331 | Anderson et al. | Jun 2005 | A1 |
| 20050182445 | Zamierowski | Aug 2005 | A1 |
| 20050209574 | Boehringer et al. | Sep 2005 | A1 |
| 20050222544 | Weston | Oct 2005 | A1 |
| 20050222613 | Ryan | Oct 2005 | A1 |
| 20050240220 | Zamierowski | Oct 2005 | A1 |
| 20050258887 | Ito et al. | Nov 2005 | A1 |
| 20050267424 | Eriksson et al. | Dec 2005 | A1 |
| 20060020269 | Cheng | Jan 2006 | A1 |
| 20060058842 | Wilke et al. | Mar 2006 | A1 |
| 20060064124 | Zhu et al. | Mar 2006 | A1 |
| 20060069357 | Marasco | Mar 2006 | A1 |
| 20060079599 | Arthur et al. | Apr 2006 | A1 |
| 20060135921 | Wiercinski et al. | Jun 2006 | A1 |
| 20060213527 | Argenta et al. | Sep 2006 | A1 |
| 20060217795 | Besselink et al. | Sep 2006 | A1 |
| 20060257457 | Gorman et al. | Nov 2006 | A1 |
| 20060259074 | Kelleher et al. | Nov 2006 | A1 |
| 20060271018 | Korf | Nov 2006 | A1 |
| 20070027414 | Hoffman et al. | Feb 2007 | A1 |
| 20070027475 | Pagedas | Feb 2007 | A1 |
| 20070032755 | Walsh | Feb 2007 | A1 |
| 20070032763 | Vogel | Feb 2007 | A1 |
| 20070038172 | Zamierowski | Feb 2007 | A1 |
| 20070052144 | Knirck et al. | Mar 2007 | A1 |
| 20070055209 | Patel | Mar 2007 | A1 |
| 20070104941 | Kameda et al. | May 2007 | A1 |
| 20070118096 | Smith et al. | May 2007 | A1 |
| 20070123816 | Zhu et al. | May 2007 | A1 |
| 20070123973 | Roth et al. | May 2007 | A1 |
| 20070129660 | McLeod et al. | Jun 2007 | A1 |
| 20070149910 | Zocher | Jun 2007 | A1 |
| 20070161937 | Aali | Jul 2007 | A1 |
| 20070179421 | Farrow | Aug 2007 | A1 |
| 20070185463 | Mulligan | Aug 2007 | A1 |
| 20070213597 | Wooster | Sep 2007 | A1 |
| 20070219513 | Lina et al. | Sep 2007 | A1 |
| 20070265585 | Joshi et al. | Nov 2007 | A1 |
| 20070282309 | Bengtson et al. | Dec 2007 | A1 |
| 20070282374 | Sogard et al. | Dec 2007 | A1 |
| 20070299541 | Chernomorsky et al. | Dec 2007 | A1 |
| 20080041401 | Casola et al. | Feb 2008 | A1 |
| 20080103462 | Wenzel et al. | May 2008 | A1 |
| 20080108977 | Heaton et al. | May 2008 | A1 |
| 20080167593 | Fleischmann | Jul 2008 | A1 |
| 20080177253 | Boehringer et al. | Jul 2008 | A1 |
| 20080243096 | Svedman et al. | Oct 2008 | A1 |
| 20080275409 | Kane et al. | Nov 2008 | A1 |
| 20080287973 | Aster et al. | Nov 2008 | A1 |
| 20080306456 | Riesinger | Dec 2008 | A1 |
| 20090005716 | Abuzaina et al. | Jan 2009 | A1 |
| 20090005744 | Karpowicz et al. | Jan 2009 | A1 |
| 20090018578 | Wilke et al. | Jan 2009 | A1 |
| 20090018579 | Wilke et al. | Jan 2009 | A1 |
| 20090043268 | Eddy et al. | Feb 2009 | A1 |
| 20090069760 | Finklestein | Mar 2009 | A1 |
| 20090069904 | Picha | Mar 2009 | A1 |
| 20090093550 | Rolfes et al. | Apr 2009 | A1 |
| 20090099519 | Kaplan | Apr 2009 | A1 |
| 20090105670 | Bentley et al. | Apr 2009 | A1 |
| 20090131888 | Joshi | May 2009 | A1 |
| 20090137973 | Karpowicz et al. | May 2009 | A1 |
| 20090204423 | Degheest et al. | Aug 2009 | A1 |
| 20090227938 | Fasching et al. | Sep 2009 | A1 |
| 20090227969 | Jaeb et al. | Sep 2009 | A1 |
| 20090246238 | Gorman et al. | Oct 2009 | A1 |
| 20090259203 | Hu et al. | Oct 2009 | A1 |
| 20090299255 | Kazala, Jr. et al. | Dec 2009 | A1 |
| 20090299256 | Barta et al. | Dec 2009 | A1 |
| 20090299303 | Seegert | Dec 2009 | A1 |
| 20090299307 | Barta et al. | Dec 2009 | A1 |
| 20090299341 | Kazala, Jr. et al. | Dec 2009 | A1 |
| 20090299342 | Cavanaugh, II et al. | Dec 2009 | A1 |
| 20090312685 | Olsen et al. | Dec 2009 | A1 |
| 20100022972 | Lina et al. | Jan 2010 | A1 |
| 20100022990 | Karpowicz et al. | Jan 2010 | A1 |
| 20100028407 | Del et al. | Feb 2010 | A1 |
| 20100030132 | Niezgoda et al. | Feb 2010 | A1 |
| 20100036333 | Schenk, III et al. | Feb 2010 | A1 |
| 20100047324 | Fritz et al. | Feb 2010 | A1 |
| 20100081983 | Zocher et al. | Apr 2010 | A1 |
| 20100087854 | Stopek et al. | Apr 2010 | A1 |
| 20100100022 | Greener et al. | Apr 2010 | A1 |
| 20100100063 | Joshi et al. | Apr 2010 | A1 |
| 20100106106 | Heaton et al. | Apr 2010 | A1 |
| 20100106184 | Coward et al. | Apr 2010 | A1 |
| 20100106188 | Heaton et al. | Apr 2010 | A1 |
| 20100121286 | Locke et al. | May 2010 | A1 |
| 20100121287 | Smith et al. | May 2010 | A1 |
| 20100125233 | Edward S. et al. | May 2010 | A1 |
| 20100137775 | Hu et al. | Jun 2010 | A1 |
| 20100137890 | Martinez et al. | Jun 2010 | A1 |
| 20100150991 | Bernstein | Jun 2010 | A1 |
| 20100160874 | Robinson et al. | Jun 2010 | A1 |
| 20100160876 | Robinson et al. | Jun 2010 | A1 |
| 20100160901 | Hu et al. | Jun 2010 | A1 |
| 20100179515 | Swain et al. | Jul 2010 | A1 |
| 20100198128 | Turnlund et al. | Aug 2010 | A1 |
| 20100211030 | Turner et al. | Aug 2010 | A1 |
| 20100256672 | Weinberg et al. | Oct 2010 | A1 |
| 20100262092 | Hartwell | Oct 2010 | A1 |
| 20100262106 | Hartwell | Oct 2010 | A1 |
| 20100262126 | Hu et al. | Oct 2010 | A1 |
| 20100280468 | Haggstrom et al. | Nov 2010 | A1 |
| 20100292717 | Petter-Puchner et al. | Nov 2010 | A1 |
| 20100305490 | Coulthard et al. | Dec 2010 | A1 |
| 20100312159 | Aali et al. | Dec 2010 | A1 |
| 20100318046 | Boehringer et al. | Dec 2010 | A1 |
| 20110004173 | Hu et al. | Jan 2011 | A1 |
| 20110009838 | Greener | Jan 2011 | A1 |
| 20110015594 | Hu et al. | Jan 2011 | A1 |
| 20110015595 | Robinson et al. | Jan 2011 | A1 |
| 20110021965 | Karp et al. | Jan 2011 | A1 |
| 20110022082 | Burke et al. | Jan 2011 | A1 |
| 20110054283 | Shuler | Mar 2011 | A1 |
| 20110054365 | Greener | Mar 2011 | A1 |
| 20110059291 | Boyce et al. | Mar 2011 | A1 |
| 20110060204 | Weston | Mar 2011 | A1 |
| 20110066096 | Svedman | Mar 2011 | A1 |
| 20110077605 | Karpowicz et al. | Mar 2011 | A1 |
| 20110082480 | Viola | Apr 2011 | A1 |
| 20110105963 | Hu et al. | May 2011 | A1 |
| 20110106026 | Wu et al. | May 2011 | A1 |
| 20110110996 | Schoenberger et al. | May 2011 | A1 |
| 20110112458 | Holm et al. | May 2011 | A1 |
| 20110113559 | Dodd | May 2011 | A1 |
| 20110130774 | Criscuolo et al. | Jun 2011 | A1 |
| 20110152800 | Eckstein et al. | Jun 2011 | A1 |
| 20110172760 | Anderson | Jul 2011 | A1 |
| 20110178451 | Robinson et al. | Jul 2011 | A1 |
| 20110196420 | Ebner | Aug 2011 | A1 |
| 20110213287 | Lattimore et al. | Sep 2011 | A1 |
| 20110213319 | Blott et al. | Sep 2011 | A1 |
| 20110224631 | Simmons et al. | Sep 2011 | A1 |
| 20110224632 | Zimnitsky et al. | Sep 2011 | A1 |
| 20110224634 | Locke et al. | Sep 2011 | A1 |
| 20110236460 | Stopek et al. | Sep 2011 | A1 |
| 20110238026 | Zhang et al. | Sep 2011 | A1 |
| 20110238095 | Browning | Sep 2011 | A1 |
| 20110238110 | Wilke et al. | Sep 2011 | A1 |
| 20110245682 | Robinson et al. | Oct 2011 | A1 |
| 20110245788 | Marquez | Oct 2011 | A1 |
| 20110264138 | Avelar et al. | Oct 2011 | A1 |
| 20110270201 | Bubb et al. | Nov 2011 | A1 |
| 20110270301 | Cornet et al. | Nov 2011 | A1 |
| 20110275964 | Greener | Nov 2011 | A1 |
| 20110282136 | Browning | Nov 2011 | A1 |
| 20110282309 | Adie et al. | Nov 2011 | A1 |
| 20110282310 | Boehringer et al. | Nov 2011 | A1 |
| 20110305736 | Wieland et al. | Dec 2011 | A1 |
| 20110313374 | Lockwood et al. | Dec 2011 | A1 |
| 20110319804 | Greener | Dec 2011 | A1 |
| 20120004631 | Hartwell | Jan 2012 | A9 |
| 20120010637 | Stopek et al. | Jan 2012 | A1 |
| 20120016321 | Wu et al. | Jan 2012 | A1 |
| 20120016322 | Coulthard et al. | Jan 2012 | A1 |
| 20120029449 | Khosrowshahi | Feb 2012 | A1 |
| 20120029455 | Perez-Foullerat et al. | Feb 2012 | A1 |
| 20120035560 | Eddy et al. | Feb 2012 | A1 |
| 20120041402 | Greener | Feb 2012 | A1 |
| 20120059399 | Hoke et al. | Mar 2012 | A1 |
| 20120059412 | Fleischmann | Mar 2012 | A1 |
| 20120065664 | Avitable et al. | Mar 2012 | A1 |
| 20120071841 | Bengtson | Mar 2012 | A1 |
| 20120073736 | O'Connor et al. | Mar 2012 | A1 |
| 20120083755 | Lina et al. | Apr 2012 | A1 |
| 20120095426 | Visscher et al. | Apr 2012 | A1 |
| 20120109188 | Viola | May 2012 | A1 |
| 20120121556 | Fraser et al. | May 2012 | A1 |
| 20120123358 | Hall et al. | May 2012 | A1 |
| 20120130327 | Marquez | May 2012 | A1 |
| 20120136326 | Croizat et al. | May 2012 | A1 |
| 20120136328 | Johannison et al. | May 2012 | A1 |
| 20120143113 | Robinson et al. | Jun 2012 | A1 |
| 20120143158 | Yang et al. | Jun 2012 | A1 |
| 20120144989 | Du et al. | Jun 2012 | A1 |
| 20120150078 | Chen et al. | Jun 2012 | A1 |
| 20120150133 | Heaton et al. | Jun 2012 | A1 |
| 20120157942 | Weston | Jun 2012 | A1 |
| 20120165764 | Allen et al. | Jun 2012 | A1 |
| 20120172778 | Rastegar et al. | Jul 2012 | A1 |
| 20120172926 | Hotter | Jul 2012 | A1 |
| 20120191054 | Kazala, Jr. et al. | Jul 2012 | A1 |
| 20120191132 | Sargeant | Jul 2012 | A1 |
| 20120197415 | Montanari et al. | Aug 2012 | A1 |
| 20120203189 | Barta et al. | Aug 2012 | A1 |
| 20120209226 | Simmons et al. | Aug 2012 | A1 |
| 20120209227 | Dunn | Aug 2012 | A1 |
| 20120220968 | Confalone et al. | Aug 2012 | A1 |
| 20120222687 | Czajka, Jr. et al. | Sep 2012 | A1 |
| 20120238931 | Rastegar et al. | Sep 2012 | A1 |
| 20120253302 | Corley | Oct 2012 | A1 |
| 20120277773 | Sargeant et al. | Nov 2012 | A1 |
| 20120302440 | Theliander et al. | Nov 2012 | A1 |
| 20130012891 | Gross et al. | Jan 2013 | A1 |
| 20130023842 | Song | Jan 2013 | A1 |
| 20130066365 | Belson et al. | Mar 2013 | A1 |
| 20130096518 | Hall et al. | Apr 2013 | A1 |
| 20130110058 | Adie et al. | May 2013 | A1 |
| 20130110066 | Sharma et al. | May 2013 | A1 |
| 20130131564 | Locke et al. | May 2013 | A1 |
| 20130138054 | Fleischmann | May 2013 | A1 |
| 20130150813 | Gordon et al. | Jun 2013 | A1 |
| 20130150814 | Buan | Jun 2013 | A1 |
| 20130190705 | Vess et al. | Jul 2013 | A1 |
| 20130197457 | Kazala, Jr. et al. | Aug 2013 | A1 |
| 20130204213 | Heagle et al. | Aug 2013 | A1 |
| 20130245527 | Croizat et al. | Sep 2013 | A1 |
| 20130253401 | Locke et al. | Sep 2013 | A1 |
| 20130274717 | Dunn | Oct 2013 | A1 |
| 20130310781 | Phillips et al. | Nov 2013 | A1 |
| 20130317465 | Seegert | Nov 2013 | A1 |
| 20130325142 | Hunter et al. | Dec 2013 | A1 |
| 20130331757 | Belson | Dec 2013 | A1 |
| 20140066868 | Freedman et al. | Mar 2014 | A1 |
| 20140068914 | Coward et al. | Mar 2014 | A1 |
| 20140088455 | Christensen et al. | Mar 2014 | A1 |
| 20140094730 | Greener et al. | Apr 2014 | A1 |
| 20140109560 | Ilievski et al. | Apr 2014 | A1 |
| 20140163415 | Zaiken et al. | Jun 2014 | A1 |
| 20140180225 | Dunn | Jun 2014 | A1 |
| 20140180229 | Fuller et al. | Jun 2014 | A1 |
| 20140194836 | Kazala, Jr. et al. | Jul 2014 | A1 |
| 20140194837 | Robinson et al. | Jul 2014 | A1 |
| 20140195004 | Engqvist et al. | Jul 2014 | A9 |
| 20140213994 | Hardman et al. | Jul 2014 | A1 |
| 20140228789 | Wilkes et al. | Aug 2014 | A1 |
| 20140249495 | Mumby et al. | Sep 2014 | A1 |
| 20140316359 | Collinson et al. | Oct 2014 | A1 |
| 20140336602 | Karpowicz et al. | Nov 2014 | A1 |
| 20140343517 | Jameson | Nov 2014 | A1 |
| 20140343518 | Riesinger | Nov 2014 | A1 |
| 20150000018 | Brandt | Jan 2015 | A1 |
| 20150005722 | Hu et al. | Jan 2015 | A1 |
| 20150025484 | Simmons et al. | Jan 2015 | A1 |
| 20150030806 | Fink | Jan 2015 | A1 |
| 20150057762 | Harms et al. | Feb 2015 | A1 |
| 20150065805 | Edmondson et al. | Mar 2015 | A1 |
| 20150065968 | Sealy et al. | Mar 2015 | A1 |
| 20150075697 | Gildersleeve | Mar 2015 | A1 |
| 20150080947 | Greener | Mar 2015 | A1 |
| 20150100008 | Chatterjee | Apr 2015 | A1 |
| 20150112290 | Dunn | Apr 2015 | A1 |
| 20150112311 | Hammond et al. | Apr 2015 | A1 |
| 20150119837 | Thompson, Jr. et al. | Apr 2015 | A1 |
| 20150119865 | Barta et al. | Apr 2015 | A1 |
| 20150148760 | Dodd et al. | May 2015 | A1 |
| 20150150729 | Dagger et al. | Jun 2015 | A1 |
| 20150157758 | Blücher et al. | Jun 2015 | A1 |
| 20150159066 | Hartwell et al. | Jun 2015 | A1 |
| 20150164174 | West | Jun 2015 | A1 |
| 20150174304 | Askem et al. | Jun 2015 | A1 |
| 20150190288 | Dunn et al. | Jul 2015 | A1 |
| 20150196431 | Dunn et al. | Jul 2015 | A1 |
| 20150216732 | Hartwell et al. | Aug 2015 | A1 |
| 20150320434 | Ingram et al. | Nov 2015 | A1 |
| 20150320602 | Locke et al. | Nov 2015 | A1 |
| 20150374561 | Hubbard, Jr. et al. | Dec 2015 | A1 |
| 20160022885 | Dunn et al. | Jan 2016 | A1 |
| 20160030646 | Hartwell et al. | Feb 2016 | A1 |
| 20160067939 | Liebe et al. | Mar 2016 | A1 |
| 20160144085 | Melin et al. | May 2016 | A1 |
| 20160166744 | Hartwell | Jun 2016 | A1 |
| 20160184496 | Jaecklein et al. | Jun 2016 | A1 |
| 20160235897 | Boynton et al. | Aug 2016 | A1 |
| 20160354086 | Dunn | Dec 2016 | A1 |
| 20170007462 | Hartwell et al. | Jan 2017 | A1 |
| 20170007751 | Hartwell et al. | Jan 2017 | A1 |
| 20170065751 | Toth et al. | Mar 2017 | A1 |
| 20170156611 | Burnett et al. | Jun 2017 | A1 |
| 20170281838 | Dunn | Oct 2017 | A1 |
| 20180140465 | Dunn et al. | May 2018 | A1 |
| 20190105202 | Dunn et al. | Apr 2019 | A1 |
| 20190231599 | Dagger et al. | Aug 2019 | A1 |
| 20190231944 | Dunn et al. | Aug 2019 | A1 |
| 20190262182 | Collinson et al. | Aug 2019 | A1 |
| 20200038023 | Dunn | Feb 2020 | A1 |
| 20200188564 | Dunn | Jun 2020 | A1 |
| 20200268562 | Dunn | Aug 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 2012261793 | Nov 2014 | AU |
| 2013206230 | May 2016 | AU |
| 1438904 | Aug 2003 | CN |
| 101112326 | Jan 2008 | CN |
| 101123930 | Feb 2008 | CN |
| 101208115 | Jun 2008 | CN |
| 101257938 | Sep 2008 | CN |
| 101588836 | Nov 2009 | CN |
| 201519362 | Apr 2010 | CN |
| 101744688 | Jun 2010 | CN |
| 202568632 | Jul 2010 | CN |
| 102038575 | May 2011 | CN |
| 102046117 | May 2011 | CN |
| 102196830 | Sep 2011 | CN |
| 102256637 | Nov 2011 | CN |
| 102781380 | Nov 2012 | CN |
| 103071197 | May 2013 | CN |
| 103405846 | Nov 2013 | CN |
| 103501709 | Jan 2014 | CN |
| 203408163 | Jan 2014 | CN |
| 104736110 | Jun 2015 | CN |
| 104768474 | Jul 2015 | CN |
| 104812343 | Jul 2015 | CN |
| 2949920 | Mar 1981 | DE |
| 102005007016 | Aug 2006 | DE |
| 102012001752 | Aug 2013 | DE |
| 1320342 | Jun 2003 | EP |
| 2094211 | Sep 2009 | EP |
| 2279016 | Feb 2011 | EP |
| 2341955 | Jul 2011 | EP |
| 2366721 | Sep 2011 | EP |
| 2367517 | Sep 2011 | EP |
| 2368523 | Sep 2011 | EP |
| 2404571 | Jan 2012 | EP |
| 2404626 | Jan 2012 | EP |
| 2529767 | Dec 2012 | EP |
| 2547375 | Jan 2013 | EP |
| 2563421 | Mar 2013 | EP |
| 2567682 | Mar 2013 | EP |
| 2567717 | Mar 2013 | EP |
| 2594299 | May 2013 | EP |
| 2601984 | Jun 2013 | EP |
| 2623137 | Aug 2013 | EP |
| 2759265 | Jul 2014 | EP |
| 2829287 | Jan 2015 | EP |
| 2852419 | Apr 2015 | EP |
| 2872085 | May 2015 | EP |
| 3225261 | Oct 2017 | EP |
| 2378392 | Feb 2003 | GB |
| 2389794 | Dec 2003 | GB |
| 2423019 | Aug 2006 | GB |
| 2489947 | Oct 2012 | GB |
| 2496310 | May 2013 | GB |
| 20140129 | Mar 2016 | IE |
| S6257560 | Mar 1987 | JP |
| H0341952 | Feb 1991 | JP |
| 109-503923 | Apr 1997 | JP |
| 2006528038 | Dec 2006 | JP |
| 2007-505678 | Mar 2007 | JP |
| 2007-531567 | Nov 2007 | JP |
| 2008-529618 | Aug 2008 | JP |
| 2009525087 | Jul 2009 | JP |
| 2009-536851 | Oct 2009 | JP |
| 2010-526597 | Aug 2010 | JP |
| 2011-500170 | Jan 2011 | JP |
| 2011521740 | Jul 2011 | JP |
| 2011-523575 | Aug 2011 | JP |
| 2011-526798 | Oct 2011 | JP |
| 2012-504460 | Feb 2012 | JP |
| 2012-105840 | Jun 2012 | JP |
| 2012-513826 | Jun 2012 | JP |
| 2012529974 | Nov 2012 | JP |
| 2013-526938 | Jun 2013 | JP |
| 2014168573 | Sep 2014 | JP |
| 62504 | Apr 2007 | RU |
| 1818103 | May 1993 | SU |
| 199420041 | Sep 1994 | WO |
| 200059424 | Oct 2000 | WO |
| 200134223 | May 2001 | WO |
| 2001085248 | Nov 2001 | WO |
| 200189392 | Nov 2001 | WO |
| 0205737 | Jan 2002 | WO |
| 03003948 | Jan 2003 | WO |
| WO-03049598 | Jun 2003 | WO |
| 2004018020 | Mar 2004 | WO |
| 2004037334 | May 2004 | WO |
| 2005046761 | May 2005 | WO |
| WO 2005105174 | Nov 2005 | WO |
| 2006041496 | Apr 2006 | WO |
| 2006046060 | May 2006 | WO |
| 2006087021 | Aug 2006 | WO |
| 2006100053 | Sep 2006 | WO |
| 2007030601 | Mar 2007 | WO |
| 2007120138 | Oct 2007 | WO |
| 2007133618 | Nov 2007 | WO |
| 2008005532 | Jan 2008 | WO |
| WO 2008027449 | Mar 2008 | WO |
| 2008039223 | Apr 2008 | WO |
| 2008039839 | Apr 2008 | WO |
| 2008064502 | Jun 2008 | WO |
| 2008091521 | Jul 2008 | WO |
| 2008104609 | Sep 2008 | WO |
| 2009019495 | Feb 2009 | WO |
| 2009071926 | Jun 2009 | WO |
| 2009071933 | Jun 2009 | WO |
| 2009093116 | Jul 2009 | WO |
| 2009112848 | Sep 2009 | WO |
| 2009114624 | Sep 2009 | WO |
| 2009112062 | Sep 2009 | WO |
| 2009158125 | Dec 2009 | WO |
| 2009158132 | Dec 2009 | WO |
| 2009156709 | Dec 2009 | WO |
| 2010033725 | Mar 2010 | WO |
| 2010051073 | May 2010 | WO |
| 2010059612 | May 2010 | WO |
| 2010075178 | Jul 2010 | WO |
| 2010075180 | Jul 2010 | WO |
| 2010078349 | Jul 2010 | WO |
| 2010079359 | Jul 2010 | WO |
| 2010092334 | Aug 2010 | WO |
| 2010097570 | Sep 2010 | WO |
| 2010147535 | Dec 2010 | WO |
| 2011023384 | Mar 2011 | WO |
| 2011087871 | Jul 2011 | WO |
| 2011091169 | Jul 2011 | WO |
| 2011106722 | Sep 2011 | WO |
| 2011115908 | Sep 2011 | WO |
| 2011116691 | Sep 2011 | WO |
| 2011135284 | Nov 2011 | WO |
| 2011135286 | Nov 2011 | WO |
| 2011135287 | Nov 2011 | WO |
| 2011144888 | Nov 2011 | WO |
| 2011137230 | Nov 2011 | WO |
| 2012021553 | Feb 2012 | WO |
| 2012038727 | Mar 2012 | WO |
| 2012069793 | May 2012 | WO |
| 2012069794 | May 2012 | WO |
| 2012082716 | Jun 2012 | WO |
| 2012082876 | Jun 2012 | WO |
| 2012087376 | Jun 2012 | WO |
| 2012106590 | Aug 2012 | WO |
| 2012112204 | Aug 2012 | WO |
| 2012136707 | Oct 2012 | WO |
| 2012142473 | Oct 2012 | WO |
| 2012156655 | Nov 2012 | WO |
| 2012168678 | Dec 2012 | WO |
| 2013007973 | Jan 2013 | WO |
| 2013012381 | Jan 2013 | WO |
| 2013043258 | Mar 2013 | WO |
| 2013074829 | May 2013 | WO |
| 2013076450 | May 2013 | WO |
| 2013071243 | May 2013 | WO |
| 2013079947 | Jun 2013 | WO |
| WO-2013079447 | Jun 2013 | WO |
| 2013175309 | Nov 2013 | WO |
| 2013175310 | Nov 2013 | WO |
| 2013136181 | Nov 2013 | WO |
| 2014013348 | Jan 2014 | WO |
| 2014014842 | Jan 2014 | WO |
| 2014014871 | Jan 2014 | WO |
| 2014014922 | Jan 2014 | WO |
| 2014024048 | Feb 2014 | WO |
| 2014140578 | Sep 2014 | WO |
| 2014158526 | Oct 2014 | WO |
| 2014165275 | Oct 2014 | WO |
| 2014178945 | Nov 2014 | WO |
| 2014194786 | Dec 2014 | WO |
| 2015008054 | Jan 2015 | WO |
| 2015061352 | Apr 2015 | WO |
| 2015109359 | Jul 2015 | WO |
| 2015110409 | Jul 2015 | WO |
| 2015110410 | Jul 2015 | WO |
| 2015169637 | Nov 2015 | WO |
| 2015172108 | Nov 2015 | WO |
| 2015193257 | Dec 2015 | WO |
| 2016018448 | Feb 2016 | WO |
| 2016176513 | Nov 2016 | WO |
| 2016179245 | Nov 2016 | WO |
| 2016184913 | Nov 2016 | WO |
| 2017063036 | Apr 2017 | WO |
| 2017106576 | Jun 2017 | WO |
| 2018038665 | Mar 2018 | WO |
| 2018041805 | Mar 2018 | WO |
| 2018044944 | Mar 2018 | WO |
| 2018044949 | Mar 2018 | WO |
| 2018237206 | Dec 2018 | WO |
| Entry |
|---|
| “Definition of Oculiform,” Webster's Revised Unabridged Dictionary, accessed from The Free Dictionary on May 30, 2018 from URL: https://www.thefreedictionary.com/Oculiform, 1913, 1 page. |
| Bengezi et al., Elevation as a treatment for fasciotomy wound closure. Can J Plast Surg. 2013 Fall;21(3):192-4. |
| Epstein et al., Lipoabdominoplasty Without Drains or Progressive Tension Sutures: An Analysis of 100 Consecutive Patients. Aesthetic Surgery Journal. Apr. 2015;35(4):434-440. |
| Jauregui et al., Fasciotomy closure techniques. J Orthop Surg (Hong Kong). Jan. 2017;25(1):2309499016684724. 8 pages. |
| Macias et al., Decrease in Seroma Rate After Adopting Progressive Tension Sutures Without Drains: A Single Surgery Center Experience of 451 Abdominoplasties over 7 Years. Aesthetic Surgery Journal. Mar. 2016;36(9):1029-1035. |
| Pollock et al., Progressive Tension Sutures in Abdominoplasty: A Review of 597 Consecutive Cases. Aesthetic Surgery Journal. Aug. 2012;32(6):729-742. |
| Quaba et al., The no-drain, no-quilt abdominoplasty: a single-surgeon series of 271 patients. Plast Reconstr Surg. Mar. 2015;135(3):751-60. |
| Rothenberg et al., Emerging Insights on Closed Incision NPWT and Transmetatarsal Amputations. http://www.podiatrytoday.com/emerging-insights-closed-incision-npwt-and-transmetatarsal-amputations. Apr. 2015;28(4):1-5. |
| “Definition of Adhere,” The Free Dictionary, accessed on Mar. 23, 2017 from http://www.thefreedictionary.com/adhere, 6 pages. |
| “Definition of Throughout,” Merriam-Webster Dictionary, accessed on Aug. 29, 2017 from https://www.merriam-webster.com/dictionary/throughout, 11 pages. |
| Hougaard, et al., “The Open Abdomen: Temporary Closure with a Modified Negative Pressure Therapy Technique,” International Wound Journal, ISSN 1742-4801, 2014, pp. 13-16. |
| International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2013/050619, dated Jan. 20, 2015, 9 pages. |
| International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2013/050698, dated Jan. 20, 2015, 9 pages. |
| International Search Report and Written Opinion for Application No. PCT/US2013/050619, dated Oct. 14, 2013, 14 pages. |
| International Search Report and Written Opinion for Application No. PCT/US2013/050698, dated Oct. 14, 2013, 14 pages. |
| Kapischke M., et al., “Self-Fixating Mesh for the Lichtenstein Procedure—a Prestudy,” Langenbecks Arch Surg, 2010, vol. 395, pp. 317-322. |
| Number | Date | Country | |
|---|---|---|---|
| 20190290495 A1 | Sep 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61672225 | Jul 2012 | US | |
| 61771732 | Mar 2013 | US | |
| 61780629 | Mar 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14415470 | US | |
| Child | 16191237 | US |
